[
  {
    "commentName": "DRVHigh",
    "drugClass": "PI",
    "conditionType": "DRUGLEVEL",
    "conditionValue": {
      "drug": "DRV",
      "levels": [
        5.0
      ]
    },
    "comment": "There is evidence for high-level DRV resistance. If DRV is administered it should be used twice daily."
  },
  {
    "commentName": "DRVHighAndTPVIntermediate",
    "drugClass": "PI",
    "conditionType": "DRUGLEVEL",
    "conditionValue": {
      "and": [
        {
          "drug": "DRV",
          "levels": [
            5.0
          ]
        },
        {
          "drug": "TPV",
          "levels": [
            4.0
          ]
        }
      ]
    },
    "comment": "There is high-level DRV resistance and intermediate TPV resistance. Phenotypic testing and/or expert consultation may be useful. To see the precise TPV report re-run the program after adding TPV to the results being displayed."
  },
  {
    "commentName": "DRVHighAndTPVLow",
    "drugClass": "PI",
    "conditionType": "DRUGLEVEL",
    "conditionValue": {
      "and": [
        {
          "drug": "DRV",
          "levels": [
            5.0
          ]
        },
        {
          "drug": "TPV",
          "levels": [
            3.0
          ]
        }
      ]
    },
    "comment": "There is high-level DRV resistance and low-level TPV resistance. Phenotypic testing and/or expert consultation may be useful. To see the precise TPV report re-run the program after adding TPV to the results being displayed."
  },
  {
    "commentName": "DRVHighAndTPVPotentialLow",
    "drugClass": "PI",
    "conditionType": "DRUGLEVEL",
    "conditionValue": {
      "and": [
        {
          "drug": "DRV",
          "levels": [
            5.0
          ]
        },
        {
          "drug": "TPV",
          "levels": [
            2.0
          ]
        }
      ]
    },
    "comment": "There is high-level DRV resistance and potential low-level TPV resistance. Phenotypic testing and/or expert consultation may be useful. To see the precise TPV report re-run the program after adding TPV to the results being displayed."
  },
  {
    "commentName": "DRVHighAndTPVSusceptible",
    "drugClass": "PI",
    "conditionType": "DRUGLEVEL",
    "conditionValue": {
      "and": [
        {
          "drug": "DRV",
          "levels": [
            5.0
          ]
        },
        {
          "drug": "TPV",
          "levels": [
            1.0
          ]
        }
      ]
    },
    "comment": "There is high-level DRV resistance and TPV susceptibility. Phenotypic testing and/or expert consultation may be useful. To see the precise TPV report re-run the program after adding TPV to the results being displayed."
  },
  {
    "commentName": "DRVIntermediate",
    "drugClass": "PI",
    "conditionType": "DRUGLEVEL",
    "conditionValue": {
      "drug": "DRV",
      "levels": [
        4.0
      ]
    },
    "comment": "There is evidence for intermediate DRV resistance. If DRV is administered it should be used twice daily."
  },
  {
    "commentName": "DRVLow",
    "drugClass": "PI",
    "conditionType": "DRUGLEVEL",
    "conditionValue": {
      "drug": "DRV",
      "levels": [
        3.0
      ]
    },
    "comment": "There is evidence for low-level DRV resistance. If DRV is administered it should be used twice daily."
  },
  {
    "commentName": "DTGHigh",
    "drugClass": "INSTI",
    "conditionType": "DRUGLEVEL",
    "conditionValue": {
      "drug": "DTG",
      "levels": [
        5.0
      ]
    },
    "comment": "There is evidence for high-level DTG resistance. If DTG is used, it should be administered twice daily."
  },
  {
    "commentName": "DTGIntermediate",
    "drugClass": "INSTI",
    "conditionType": "DRUGLEVEL",
    "conditionValue": {
      "drug": "DTG",
      "levels": [
        4.0
      ]
    },
    "comment": "There is evidence for intermediate DTG resistance. If DTG is used, it should be administered twice daily."
  },
  {
    "commentName": "DTGLow",
    "drugClass": "INSTI",
    "conditionType": "DRUGLEVEL",
    "conditionValue": {
      "drug": "DTG",
      "levels": [
        3.0
      ]
    },
    "comment": "There is evidence for low-level DTG resistance. If DTG is used, it should be administered twice daily."
  },
  {
    "commentName": "IN118ACDEFHIKLMNPQSTVWY_-",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "IN",
      "pos": 118.0,
      "aas": "ACDEFHIKLMNPQSTVWY_-"
    },
    "comment": "G118R is an extremely rare non-polymorphic mutation selected in patients receiving RAL and DTG and in vitro by DTG. It causes intermediate reductions in RAL and EVG susceptibility and low-level reductions in DTG and BIC susceptibility. $listMutsIn{118(NOT R)} is an unusual mutation at this position."
  },
  {
    "commentName": "IN118R",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "IN",
      "pos": 118.0,
      "aas": "R"
    },
    "comment": "G118R is a rare non-polymorphic mutation selected in patients receiving RAL and DTG and in vitro by DTG. It causes a variable reduction in susceptibility to each of the INSTIs of about 5-fold."
  },
  {
    "commentName": "IN119R",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "IN",
      "pos": 119.0,
      "aas": "R"
    },
    "comment": "S119R is a polymorphic mutation that is weakly selected by INSTIs usually in combination with several major INSTI-associated DRMs. Alone, it has little, if any effect, on INSTI susceptibility . "
  },
  {
    "commentName": "IN121ACDEGHIKLMNPQRSTVW_-",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "IN",
      "pos": 121.0,
      "aas": "ACDEGHIKLMNPQRSTVW_-"
    },
    "comment": "F121Y is a non-polymorphic mutation selected in vitro by RAL and EVG. It has been reported rarely in patients receiving RAL. It causes intermediate to high-level reductions in RAL and EVG susceptibility but does not appear to reduce DTG or BIC susceptibility. $listMutsIn{121(NOT Y)} is an unusual mutation at this position."
  },
  {
    "commentName": "IN121Y",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "IN",
      "pos": 121.0,
      "aas": "Y"
    },
    "comment": "F121Y is a non-polymorphic mutation selected in vitro by RAL and EVG. It has been reported rarely in patients receiving RAL. It causes intermediate to high-level reductions in RAL and EVG susceptibility but does not appear to reduce DTG or BIC susceptibility."
  },
  {
    "commentName": "IN128T",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "IN",
      "pos": 128.0,
      "aas": "T"
    },
    "comment": "A128T is a relatively nonpolymorphic possible INSTI-selected mutation, which does not appear to reduce INSTI susceptibility "
  },
  {
    "commentName": "IN138CFGHILMNPQRSVWY_-",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "IN",
      "pos": 138.0,
      "aas": "CFGHILMNPQRSVWY_-"
    },
    "comment": "E138K/A/T are non-polymorphic mutations selected in patients receiving RAL, EVG and rarely DTG. They usually occur in combination with Q148 mutations. In combination with Q148 they cause high-level resistance to RAL and EVG and intermediate reductions in susceptibility to DTG and BIC. E138D is a polymorphism that occurs in 1% to 2% of viruses from INSTI-naive patients. It does not appear to be selected by INSTIs or to reduce INSTI susceptibility. $listMutsIn{138(NOT KATD)} is an unusual mutation at this position."
  },
  {
    "commentName": "IN138D",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "IN",
      "pos": 138.0,
      "aas": "D"
    },
    "comment": "E138D is a polymorphism that occurs in 1% to 2% of viruses from INSTI-naive patients. It does not appear to be selected by INSTIs or to reduce INSTI susceptibility."
  },
  {
    "commentName": "IN138KAT",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "IN",
      "pos": 138.0,
      "aas": "KAT"
    },
    "comment": "E138K/A are non-polymorphic mutations selected in patients receiving RAL, EVG, and DTG. They usually occur in combination with Q148 mutations. Alone they do not reduce INSTI susceptibility. However, when they occur in combination with Q148 mutations, they are associated with high-level resistance to RAL and EVG and intermediate reductions in DTG and BIC susceptibility. E138T is an uncommon nonpolymorphic INSTI-selected mutation that appears to have an effect similar to E138K/A."
  },
  {
    "commentName": "IN140DEFHIKLMNPQRTVWY_-",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "IN",
      "pos": 140.0,
      "aas": "DEFHIKLMNPQRTVWY_-"
    },
    "comment": "G140S/A/C are non-polymorphic mutations that usually occur with Q148 mutations. Alone, they have minimal effects on INSTI susceptibility. However, in combination with Q148 mutations they are associated with high-level resistance to RAL and EVG and intermediate reductions in DTG and BIC susceptibility. $listMutsIn{140(NOT SAC)} is an unusual mutation at this position."
  },
  {
    "commentName": "IN140SAC",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "IN",
      "pos": 140.0,
      "aas": "SAC"
    },
    "comment": "G140S/A/C are non-polymorphic mutations that usually occur with Q148 mutations. Alone, they have minimal effects on INSTI susceptibility. However, in combination with Q148 mutations they are associated with high-level resistance to RAL and EVG and intermediate reductions in DTG and BIC susceptibility."
  },
  {
    "commentName": "IN142T",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "IN",
      "pos": 142.0,
      "aas": "T"
    },
    "comment": "P142T is a rare nonpolymorphic mutation selected in vitro and in vivo by RAL. It usually occurs in combination with other INSTI-resistance mutations. Its effect on susceptibility has not been studied."
  },
  {
    "commentName": "IN143CR",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "IN",
      "pos": 143.0,
      "aas": "CR"
    },
    "comment": "Y143C/R are non-polymorphic mutations associated with high-level RAL resistance. Alone, they have minimal effects on EVG susceptibility. However, they are associated with intermediate to high-level reductions in EVG susceptibility when they occur in combination with one or more accessory INSTI-resistance mutations. Y143 mutations do not reduce DTG or BIC susceptibility."
  },
  {
    "commentName": "IN143DEFILMNPQTVW_-",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "IN",
      "pos": 143.0,
      "aas": "DEFILMNPQTVW_-"
    },
    "comment": "Y143C/R are non-polymorphic mutations associated with high-level RAL resistance. Alone, they have minimal effects on EVG susceptibility. However, they are associated with intermediate to high-level reductions in EVG susceptibility when they occur in combination with one or more accessory INSTI-resistance mutations. Y143 mutations do not reduce DTG or BIC susceptibility. $listMutsIn{143(NOT CRHKGSA)} is an unusual mutation at this position."
  },
  {
    "commentName": "IN143H",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "IN",
      "pos": 143.0,
      "aas": "H"
    },
    "comment": "Y143C/R are non-polymorphic mutations associated with high-level RAL resistance. Alone, they have minimal effects on EVG susceptibility. However, they are associated with intermediate to high-level reductions in EVG susceptibility when they occur in combination with one or more accessory INSTI-resistance mutations. Y143 mutations do not reduce DTG or BIC susceptibility. Y143H is a less-common mutation at this position that is likely a transitional mutation between the wildtype Y amino acid and the mutant R (which differs from the wildtype Y by two nucleotides)."
  },
  {
    "commentName": "IN143KGSA",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "IN",
      "pos": 143.0,
      "aas": "KGSA"
    },
    "comment": "Y143K/G/S/A are rare mutations that cause intermediate reductions in RAL susceptibility. When they occur in combination with other accessory mutations, they may also cause low-level reductions in EVG susceptibility."
  },
  {
    "commentName": "IN145ACDEFGHIKLMNQRTVWY_-",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "IN",
      "pos": 145.0,
      "aas": "ACDEFGHIKLMNQRTVWY_-"
    },
    "comment": "P145S is a rare non-polymorphic mutation selected in vitro by EVG and rarely in patients receiving EVG. It causes high-level resistance to EVG but not to RAL or DTG. $listMutsIn{145(NOT S)} is an unusual mutation at this position."
  },
  {
    "commentName": "IN145S",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "IN",
      "pos": 145.0,
      "aas": "S"
    },
    "comment": "P145S is a rare non-polymorphic mutation selected in vitro by EVG and rarely in patients receiving EVG. It causes high-level resistance to EVG but not to RAL or DTG."
  },
  {
    "commentName": "IN146ACDEFGHIKLMNRSTVWY_-",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "IN",
      "pos": 146.0,
      "aas": "ACDEFGHIKLMNRSTVWY_-"
    },
    "comment": "Q146P is a rare non-polymorphic mutation selected in vitro by EVG which causes low-to-intermediate reductions in EVG susceptibility. $listMutsIn{146(NOT P)} is an unusual mutation at this position."
  },
  {
    "commentName": "IN146P",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "IN",
      "pos": 146.0,
      "aas": "P"
    },
    "comment": "Q146P is a rare non-polymorphic mutation selected in vitro by EVG which causes low-to-intermediate reductions in EVG susceptibility."
  },
  {
    "commentName": "IN147ACDEFHIKLMNPQRTVWY_-",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "IN",
      "pos": 147.0,
      "aas": "ACDEFHIKLMNPQRTVWY_-"
    },
    "comment": "S147G is a non-polymorphic mutation selected primarily in patients receiving EVG. It moderately reduces EVG susceptibility. It does not reduce RAL, DTG, or BIC susceptibility. $listMutsIn{147(NOT G)} is an unusual mutation at this position."
  },
  {
    "commentName": "IN147G",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "IN",
      "pos": 147.0,
      "aas": "G"
    },
    "comment": "S147G is a non-polymorphic mutation selected primarily in patients receiving EVG. It moderately reduces EVG susceptibility. It does not reduce RAL, DTG, or BIC susceptibility."
  },
  {
    "commentName": "IN148ACDEFGILMPSTVWY_-",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "IN",
      "pos": 148.0,
      "aas": "ACDEFGILMPSTVWY_-"
    },
    "comment": "Q148H/K/R are non-polymorphic mutations selected by RAL, EVG, and rarely DTG. Q148H/R/K are associated with high-level reductions in RAL and EVG susceptibility particularly when they occur In combination with E138 or G140 mutations. Alone, Q148H/K/R have minimal effects on DTG and BIC susceptibility. But in combination with E138 and G140 mutations they cause moderate and occasionally high-level reductions in DTG and BIC susceptibility. $listMutsIn{148(NOT HKRN)} is an unusual mutation at this position."
  },
  {
    "commentName": "IN148HKR",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "IN",
      "pos": 148.0,
      "aas": "HKR"
    },
    "comment": "Q148H/K/R are non-polymorphic mutations selected by RAL, EVG, and rarely DTG. Q148H/R/K are associated with high-level reductions in RAL and EVG susceptibility particularly when they occur In combination with E138 or G140 mutations. Alone, Q148H/K/R have minimal effects on DTG and BIC susceptibility. But in combination with E138 and G140 mutations they cause moderate and occasionally high-level reductions in DTG and BIC susceptibility."
  },
  {
    "commentName": "IN148N",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "IN",
      "pos": 148.0,
      "aas": "N"
    },
    "comment": "Q148H/K/R are non-polymorphic mutations selected by RAL, EVG, and rarely DTG. Q148H/R/K are associated with high-level reductions in RAL and EVG susceptibility particularly when they occur In combination with E138 or G140 mutations. Alone, Q148H/K/R have minimal effects on DTG and BIC susceptibility. But in combination with E138 and G140 mutations they cause moderate and occasionally high-level reductions in DTG and BIC susceptibility. Q148N is a rare INSTI-selected mutation that causes ~3-fold reduced EVG susceptibility and may represent a reversion from Q148H or Q148K."
  },
  {
    "commentName": "IN149A",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "IN",
      "pos": 149.0,
      "aas": "A"
    },
    "comment": "G149A selected in vivo by DTG in RAL experienced patients. It appears to have no effect by itself but in combination with mutations at positions 140 and 148, it reduces DTG susceptibility. "
  },
  {
    "commentName": "IN151A",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "IN",
      "pos": 151.0,
      "aas": "A"
    },
    "comment": "V151A is an extremely rare non-polymorphic mutation associated with minimally reduced susceptibility to RAL and EVG."
  },
  {
    "commentName": "IN151CDEFGHKMNPQRSTWY_-",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "IN",
      "pos": 151.0,
      "aas": "CDEFGHKMNPQRSTWY_-"
    },
    "comment": "V151I is an accessory INSTI selected mutation that occurs in 1% to 5% of viruses from ARV-naive patients depending on subtype. It appears to have little or no effect on INSTI susceptibility. V151L is an extremely rare non-polymorphic mutation that confers intermediate / high-level reduced susceptibility to RAL and EVG and low-level reduced susceptibility to DTG. V151A is an extremely rare non-polymorphic mutation associated with minimally reduced susceptibility to RAL and EVG. $listMutsIn{151(NOT IAL)} is an unusual mutation at this position."
  },
  {
    "commentName": "IN151I",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "IN",
      "pos": 151.0,
      "aas": "I"
    },
    "comment": "V151I is an accessory INSTI selected mutation that occurs in 1% to 5% of viruses from ARV-naive patients depending on subtype. Alone, it appears to have little or no effect on INSTI susceptibility."
  },
  {
    "commentName": "IN151L",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "IN",
      "pos": 151.0,
      "aas": "L"
    },
    "comment": "V151L is an extremely rare non-polymorphic mutation that confers intermediate / high-level reduced susceptibility to RAL and EVG and low-level reduced susceptibility to DTG."
  },
  {
    "commentName": "IN153ACDEGHIKLMNPQRTVW_-",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "IN",
      "pos": 153.0,
      "aas": "ACDEGHIKLMNPQRTVW_-"
    },
    "comment": "S153Y/F are rare non-polymorphic mutations selected in vitro by EVG, DTG, and BIC. S153Y/F reduce RAL, DTG, and possibly BIC susceptibility about 2-fold and EVG susceptibility about 4-fold. $listMutsIn{153(NOT YF)} is an unusual mutation at this position."
  },
  {
    "commentName": "IN153YF",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "IN",
      "pos": 153.0,
      "aas": "YF"
    },
    "comment": "S153Y/F are rare non-polymorphic mutations selected in vitro by EVG, DTG, and BIC. S153Y/F reduce RAL, DTG, and possibly BIC susceptibility about 2-fold and EVG susceptibility about 4-fold."
  },
  {
    "commentName": "IN155ACDEFGIKLMPQRVWY_-",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "IN",
      "pos": 155.0,
      "aas": "ACDEFGIKLMPQRVWY_-"
    },
    "comment": "N155H is a non-polymorphic mutation selected in patients receiving RAL, EVG, and rarely DTG. It is associated with high-level reductions in RAL and EVG susceptibility. It causes low-level reductions in DTG susceptibility. N155S/T are rare non-polymorphic mutations selected in vitro by investigational INSTIs. They reduce RAL and EVG susceptibility somewhat less than does N155H. $listMutsIn{155(NOT HST)} is an unusual mutation at this position."
  },
  {
    "commentName": "IN155H",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "IN",
      "pos": 155.0,
      "aas": "H"
    },
    "comment": "N155H is a non-polymorphic mutation selected in patients receiving RAL, EVG, and rarely DTG. It is associated with high-level reductions in RAL and EVG susceptibility. It causes low-level reductions in DTG susceptibility."
  },
  {
    "commentName": "IN155ST",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "IN",
      "pos": 155.0,
      "aas": "ST"
    },
    "comment": "N155H is a non-polymorphic mutation selected in patients receiving RAL, EVG, and rarely DTG. It is associated with high-level reductions in RAL and EVG susceptibility. It causes low-level reductions in DTG susceptibility. N155S/T are extremely rare non-polymorphic mutations selected in vitro by investigational INSTIs. They reduce RAL and EVG susceptibility somewhat less than does N155H."
  },
  {
    "commentName": "IN157Q",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "IN",
      "pos": 157.0,
      "aas": "Q"
    },
    "comment": "E157Q is a polymorphic mutation selected in patients receiving RAL and EVG. It appears to have little effect on INSTI susceptibility."
  },
  {
    "commentName": "IN163RK",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "IN",
      "pos": 163.0,
      "aas": "RK"
    },
    "comment": "G163R/K are polymorphic in subtype F viruses from ARV-naive patients but are otherwise non-polymorphic. They are common INSTI-selected mutations. Alone, they have little, if any, effect on INSTI susceptibility."
  },
  {
    "commentName": "IN230N",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "IN",
      "pos": 230.0,
      "aas": "N"
    },
    "comment": "S230N is a polymorphism that is not associated with reduced INSTI susceptibility."
  },
  {
    "commentName": "IN230R",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "IN",
      "pos": 230.0,
      "aas": "R"
    },
    "comment": "S230R is a non-polymorphic mutation selected by RAL, EVG, and DTG. It causes low-level reductions in DTG susceptibility."
  },
  {
    "commentName": "IN232N",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "IN",
      "pos": 232.0,
      "aas": "N"
    },
    "comment": "D232N is a common nonpolymorphic accessory mutation selected in patients receiving RAL and EVG."
  },
  {
    "commentName": "IN263ACDEFGHILMNPQSTVWY_-",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "IN",
      "pos": 263.0,
      "aas": "ACDEFGHILMNPQSTVWY_-"
    },
    "comment": "R263K is selected in vitro by EVG, DTG, and BIC, and in patients receiving DTG. It reduces DTG and BIC susceptibility about 2-fold and EVG susceptibility somewhat more. $listMutsIn{263(NOT K)} is an unusual mutation at this position."
  },
  {
    "commentName": "IN263K",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "IN",
      "pos": 263.0,
      "aas": "K"
    },
    "comment": "R263K is selected in vitro by EVG, DTG, and BIC, and in patients receiving DTG. It reduces DTG and BIC susceptibility about 2-fold and EVG susceptibility somewhat more. "
  },
  {
    "commentName": "IN50I",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "IN",
      "pos": 50.0,
      "aas": "I"
    },
    "comment": "M50I is a polymorphic mutation selected in vitro by DTG and BIC in combination with R263K. It appears to contribute to reduced DTG susceptibility in combination with R263K. "
  },
  {
    "commentName": "IN51ACDEFGIKLMNPQRSTVW_-",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "IN",
      "pos": 51.0,
      "aas": "ACDEFGIKLMNPQRSTVW_-"
    },
    "comment": "H51Y is a rare non-polymorphic accessory mutation selected in patients receiving RAL and EVG and in vitro by DTG. H51Y reduces EVG susceptibility 2 to 3-fold. It does not reduce RAL or DTG susceptibility. $listMutsIn{51(NOT Y)} is an unusual mutation at this position."
  },
  {
    "commentName": "IN51Y",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "IN",
      "pos": 51.0,
      "aas": "Y"
    },
    "comment": "H51Y is a rare non-polymorphic accessory mutation selected in patients receiving RAL and EVG and in vitro by DTG. H51Y minimally reduces EVG susceptibility (~2 to 3-fold). It does not reduce RAL or DTG susceptibility."
  },
  {
    "commentName": "IN66A",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "IN",
      "pos": 66.0,
      "aas": "A"
    },
    "comment": "T66A is a non-polymorphic mutation selected in patients receiving EVG and RAL, usually in combination with other INSTI-resistance mutations. It causes a moderate reduction in EVG susceptibility but does not appear to reduce RAL, DTG, or BIC susceptibility."
  },
  {
    "commentName": "IN66CDEFGHLMNPQRSVWY_-",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "IN",
      "pos": 66.0,
      "aas": "CDEFGHLMNPQRSVWY_-"
    },
    "comment": "T66A/I/K are non-polymorphic mutations selected primarily by EVG. T66K is associated with high-level EVG resistance, intermediate/high-level RAL resistance, and low-level DTG resistance. Its effect on BIC is not known. $listMutsIn{66(NOT IAK)} is an unusual mutation at this position."
  },
  {
    "commentName": "IN66I",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "IN",
      "pos": 66.0,
      "aas": "I"
    },
    "comment": "T66I is a non-polymorphic mutation selected in patients receiving EVG, RAL, and DTG. It reduces EVG susceptibility about 10-fold but does not reduce RAL, DTG, or BIC susceptibility."
  },
  {
    "commentName": "IN66K",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "IN",
      "pos": 66.0,
      "aas": "K"
    },
    "comment": "T66K is a non-polymorphic mutation selected in patients receiving EVG. It is associated with high-level EVG resistance, intermediate/high-level RAL resistance, and low-level DTG resistance. Its effect on BIC is not known."
  },
  {
    "commentName": "IN74MIF",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "IN",
      "pos": 74.0,
      "aas": "MIF"
    },
    "comment": "L74M/I are polymorphic accessory mutations commonly selected by each of the INSTIs. In ARV-naive patients, L74M occurs in 0.5% to 10% of patients and L74I occurs in 3% to 20% of patients depending on subtype. Alone, L74M/I have minimal, if any, effect on INSTI susceptibility. However, they contribute reduced susceptibility to each of the INSTIs when they occur with major INSTI-resistance mutations. L74F is a rare nonpolymorphic mutation which also contributes reduced susceptibility when it occurs with other INSTI-resistance mutations."
  },
  {
    "commentName": "IN92ACDFHIKLMNPRSTWY_-",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "IN",
      "pos": 92.0,
      "aas": "ACDFHIKLMNPRSTWY_-"
    },
    "comment": "E92Q is a common non-polymorphic mutation selected in patients receiving RAL and EVG. It reduces RAL susceptibility 5 to 10-fold and EVG susceptibility ~30-fold. It is selected in vitro by DTG and reduces DTG susceptibility ~1.5-fold. $listMutsIn{92(NOT GQV)} is an unusual mutation at this position."
  },
  {
    "commentName": "IN92G",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "IN",
      "pos": 92.0,
      "aas": "G"
    },
    "comment": "E92G is a rare non-polymorphic mutation that has been selected in patients receiving EVG. It moderately reduces EVG susceptibility but does not reduce susceptibility to RAL, DTG, or BIC."
  },
  {
    "commentName": "IN92Q",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "IN",
      "pos": 92.0,
      "aas": "Q"
    },
    "comment": "E92Q is a common non-polymorphic mutation selected in patients receiving RAL and EVG. It reduces RAL susceptibility 5 to 10-fold and EVG susceptibility ~30-fold. It is selected in vitro by DTG and reduces DTG susceptibility ~1.5-fold. It does not appear to reduce BIC susceptibility."
  },
  {
    "commentName": "IN92V",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "IN",
      "pos": 92.0,
      "aas": "V"
    },
    "comment": "E92V is a rare non-polymorphic mutation selected in vitro by an investigational INSTI. It causes intermediate and high-level reductions in EVG and RAL susceptibility, respectively."
  },
  {
    "commentName": "IN95K",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "IN",
      "pos": 95.0,
      "aas": "K"
    },
    "comment": "Q95K is a non-polymorphic INSTI-selected mutation. Alone, it has little if any effect on INSTI susceptibility."
  },
  {
    "commentName": "IN97A",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "IN",
      "pos": 97.0,
      "aas": "A"
    },
    "comment": "T97A is a polymorphic INSTI-selected mutation that, depending on subtype, occurs in 1% to 5% of viruses from untreated persons. Alone, it has minimal effects on INSTI susceptibility but in combination with other major resistance mutations, it synergistically reduces susceptibility to EVG, RAL, DTG, and possibly BIC."
  },
  {
    "commentName": "PR10ACDEGHKMNPQSTW_-",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 10.0,
      "aas": "ACDEGHKMNPQSTW_-"
    },
    "comment": "L10F/I/V/R/Y are PI-selected accessory mutations. $listMutsIn{10(NOT FIVRY)} is a highly unusual mutation at this position."
  },
  {
    "commentName": "PR10F",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 10.0,
      "aas": "F"
    },
    "comment": "L10F is a common non-polymorphic, PI-selected accessory mutation associated with reduced susceptibility to DRV, FPV, IDV, LPV, and NFV."
  },
  {
    "commentName": "PR10IV",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 10.0,
      "aas": "IV"
    },
    "comment": "L10I/V are polymorphic, PI-selected accessory mutations that increase the replication of viruses with other PI-resistance mutations."
  },
  {
    "commentName": "PR10RY",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 10.0,
      "aas": "RY"
    },
    "comment": "L10R/Y are rare, non-polymorphic PI-selected mutations. Their effects on PI susceptibility have not been well studied."
  },
  {
    "commentName": "PR11IL",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 11.0,
      "aas": "IL"
    },
    "comment": "V11I is a relatively non-polymorphic accessory mutation selected in patients receiving DRV. It is included in the Tibotec DRV genotypic susceptibility score. V11L is a nonpolymorphic PI-selected mutation associated with reduced DRV and FPV susceptibility when it occurs in combination with other PI-resistance mutations.\r\n"
  },
  {
    "commentName": "PR20I",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 20.0,
      "aas": "I"
    },
    "comment": "K20I is the consensus amino acid in subtype G and CRF02_AG. In subtypes B and C, K20I is a PI-selected accessory mutation that reduces NFV susceptibility."
  },
  {
    "commentName": "PR20MV",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 20.0,
      "aas": "MV"
    },
    "comment": "K20M/V are rare, relatively non-polymorphic PI-selected mutations that have not been well studied."
  },
  {
    "commentName": "PR20R",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 20.0,
      "aas": "R"
    },
    "comment": "K20R is a highly polymorphic PI-selected accessory mutation."
  },
  {
    "commentName": "PR20T",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 20.0,
      "aas": "T"
    },
    "comment": "K20T is a non-polymorphic accessory PI-selected mutation associated with reduced susceptibility to each of the PIs except DRV and TPV."
  },
  {
    "commentName": "PR23I",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 23.0,
      "aas": "I"
    },
    "comment": "L23I is an uncommon non-polymorphic mutation selected primarily by NFV. It causes low-level NFV resistance."
  },
  {
    "commentName": "PR24ACDEGHKNPQRSTVWY_-",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 24.0,
      "aas": "ACDEGHKNPQRSTVWY_-"
    },
    "comment": "L24I is a non-polymorphic mutation selected by IDV and LPV. It contributes reduced susceptibility to each PI except DRV and TPV. $listMutsIn{24(NOT FIM)} is a highly unusual mutation at this position."
  },
  {
    "commentName": "PR24FM",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 24.0,
      "aas": "FM"
    },
    "comment": "L24I is a non-polymorphic mutation selected by IDV and LPV. It contributes reduced susceptibility to each PI except DRV and TPV. L24F/M are uncommon non-polymorphic PI-selected mutations. L24F has a susceptibility profile similar to L24I."
  },
  {
    "commentName": "PR24I",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 24.0,
      "aas": "I"
    },
    "comment": "L24I is a non-polymorphic mutation selected by IDV and LPV. It contributes reduced susceptibility to each PI except DRV and TPV."
  },
  {
    "commentName": "PR30ACEFGHIKLMPQRSTVWY_-",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 30.0,
      "aas": "ACEFGHIKLMPQRSTVWY_-"
    },
    "comment": "D30N is a non-polymorphic mutation that causes high-level resistance to NFV. $listMutsIn{30(NOT N)} is a highly unusual mutation at this position."
  },
  {
    "commentName": "PR30N",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 30.0,
      "aas": "N"
    },
    "comment": "D30N is a non-polymorphic mutation that causes high-level resistance to NFV."
  },
  {
    "commentName": "PR32ACDEFGHKLMNPQRSTWY_-",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 32.0,
      "aas": "ACDEFGHKLMNPQRSTWY_-"
    },
    "comment": "V32I is a non-polymorphic PI-selected mutation associated with reduced susceptibility to each of the PIs except SQV. It is included in the Tibotec DRV genotypic susceptibility score. $listMutsIn{32(NOT I)} is a highly unusual mutation at this position."
  },
  {
    "commentName": "PR32I",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 32.0,
      "aas": "I"
    },
    "comment": "V32I is a non-polymorphic PI-selected mutation associated with reduced susceptibility to each of the PIs except SQV. It is included in the Tibotec DRV genotypic susceptibility score."
  },
  {
    "commentName": "PR33F",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 33.0,
      "aas": "F"
    },
    "comment": "L33F is a relatively non-polymorphic accessory mutation selected by each of the PIs. In combination with other PI-resistance mutations, it is associated with reduced susceptibility to each of the PIs. It is included in the Tibotec DRV genotypic susceptibility score."
  },
  {
    "commentName": "PR33_",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 33.0,
      "aas": "_"
    },
    "comment": "Insertions between positions 33 and 41 do not appear to be selected by PIs or to reduce PI susceptibility."
  },
  {
    "commentName": "PR34_",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 34.0,
      "aas": "_"
    },
    "comment": "Insertions between positions 33 and 41 do not appear to be selected by PIs or to reduce PI susceptibility."
  },
  {
    "commentName": "PR35_",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 35.0,
      "aas": "_"
    },
    "comment": "Insertions between positions 33 and 41 do not appear to be selected by PIs or to reduce PI susceptibility."
  },
  {
    "commentName": "PR36_",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 36.0,
      "aas": "_"
    },
    "comment": "Insertions between positions 33 and 41 do not appear to be selected by PIs or to reduce PI susceptibility."
  },
  {
    "commentName": "PR37_",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 37.0,
      "aas": "_"
    },
    "comment": "Insertions between positions 33 and 41 do not appear to be selected by PIs or to reduce PI susceptibility."
  },
  {
    "commentName": "PR38_",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 38.0,
      "aas": "_"
    },
    "comment": "Insertions between positions 33 and 41 do not appear to be selected by PIs or to reduce PI susceptibility."
  },
  {
    "commentName": "PR39_",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 39.0,
      "aas": "_"
    },
    "comment": "Insertions between positions 33 and 41 do not appear to be selected by PIs or to reduce PI susceptibility."
  },
  {
    "commentName": "PR40_",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 40.0,
      "aas": "_"
    },
    "comment": "Insertions between positions 33 and 41 do not appear to be selected by PIs or to reduce PI susceptibility."
  },
  {
    "commentName": "PR41_",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 41.0,
      "aas": "_"
    },
    "comment": "Insertions between positions 33 and 41 do not appear to be selected by PIs or to reduce PI susceptibility."
  },
  {
    "commentName": "PR43T",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 43.0,
      "aas": "T"
    },
    "comment": "K43T is a non-polymorphic PI-selected accessory mutation. K43T is included in the Boehringer-Ingelheim TPV genotypic susceptibility score."
  },
  {
    "commentName": "PR46ACDEFGHKNPQRSTWY_-",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 46.0,
      "aas": "ACDEFGHKNPQRSTWY_-"
    },
    "comment": "M46I/L are relatively non-polymorphic PI-selected mutations. In combination with other PI-resistance mutations, they are associated with reduced susceptibility to each of the PIs except DRV. $listMutsIn{46(NOT ILV)} is a highly unusual mutation at this position."
  },
  {
    "commentName": "PR46IL",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 46.0,
      "aas": "IL"
    },
    "comment": "M46I/L are relatively non-polymorphic PI-selected mutations. In combination with other PI-resistance mutations, they are associated with reduced susceptibility to each of the PIs except DRV."
  },
  {
    "commentName": "PR46V",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 46.0,
      "aas": "V"
    },
    "comment": "M46I/L are relatively non-polymorphic PI-selected mutations. In combination with other PI-resistance mutations, they are associated with reduced susceptibility to each of the PIs except DRV. M46V is a rare non-polymorphic PI-selected mutation that has not been well studied.\r\n"
  },
  {
    "commentName": "PR47A",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 47.0,
      "aas": "A"
    },
    "comment": "I47A is a non-polymorphic mutation selected by LPV. It usually occurs in combination with V32I and in this context it confers high-level resistance to LPV and FPV and low/intermediate-resistance to the remaining PIs except ATV and SQV."
  },
  {
    "commentName": "PR47CDEFGHKLMNPQRSTWY_-",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 47.0,
      "aas": "CDEFGHKLMNPQRSTWY_-"
    },
    "comment": "I47V is a non-polymorphic PI-selected mutation associated with reduced susceptibility to each of the PIs except SQV and ATV. I47A is a non-polymorphic mutation selected by LPV. It usually occurs in combination with V32I and in this context it confers high-level resistance to LPV and FPV and low/intermediate-resistance to the remaining PIs except ATV and SQV. $listMutsIn{47(NOT AV)} is a highly unusual mutation at this position."
  },
  {
    "commentName": "PR47V",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 47.0,
      "aas": "V"
    },
    "comment": "I47V is a non-polymorphic PI-selected mutation associated with reduced susceptibility to each of the PIs except SQV and ATV. I47V is included in the Tibotec DRV genotypic susceptibility score."
  },
  {
    "commentName": "PR48ASTQL",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 48.0,
      "aas": "ASTQL"
    },
    "comment": "G48V is a non-polymorphic mutation selected by SQV and, less often, by IDV and LPV. It confers high-level resistance to SQV, intermediate resistance to ATV, and low-level resistance to NFV, IDV and LPV. G48M is a non-polymorphic mutation selected in viruses with multiple PI-resistance mutations. Its effects appear to be similar to those of G48V. G48A/S/T/Q are rare non-polymorphic mutations selected in viruses with multiple PI-resistance mutations."
  },
  {
    "commentName": "PR48CDEFHIKNPRWY_-",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 48.0,
      "aas": "CDEFHIKNPRWY_-"
    },
    "comment": "G48V is a non-polymorphic mutation selected by SQV and, less often, by IDV and LPV. It confers high-level resistance to SQV, intermediate-level resistance to ATV, and low-level resistance to NFV, IDV and LPV. G48M is a non-polymorphic mutation selected in viruses with multiple PI-resistance mutations. Its effects appear to be similar to those of G48V. G48A/S/T/Q are rare non-polymorphic mutations selected in viruses with multiple PI-resistance mutations. $listMutsIn{48(NOT VMALSTQL)} is a highly unusual mutation at this position."
  },
  {
    "commentName": "PR48M",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 48.0,
      "aas": "M"
    },
    "comment": "G48V is a non-polymorphic mutation selected by SQV and, less often, by IDV and LPV. It confers high-level resistance to SQV, intermediate resistance to ATV, and low-level resistance to NFV, IDV and LPV. G48M is a non-polymorphic mutation selected in viruses with multiple PI-resistance mutations. Its effects appear to be similar to those of G48V."
  },
  {
    "commentName": "PR48V",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 48.0,
      "aas": "V"
    },
    "comment": "G48V is a non-polymorphic mutation selected by SQV and, less often, by IDV and LPV. It confers high-level resistance to SQV, intermediate resistance to ATV, and low-level resistance to NFV, IDV and LPV."
  },
  {
    "commentName": "PR50ACDEFGHKMNPQRSTWY_-",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 50.0,
      "aas": "ACDEFGHKMNPQRSTWY_-"
    },
    "comment": "I50V is a non-polymorphic mutation selected by DRV, LPV and FPV. It causes low-level, intermediate, and high-level resistance to DRV, LPV, and FPV, respectively. I50L is a non-polymorphic mutation selected by ATV. It causes high-level resistance to ATV and increases susceptibility to the remaining PIs. $listMutsIn{50(NOT LV)} is a highly unusual mutation at this position."
  },
  {
    "commentName": "PR50L",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 50.0,
      "aas": "L"
    },
    "comment": "I50L is a non-polymorphic mutation selected by ATV. It causes high-level resistance to ATV and increases susceptibility to most of the remaining PIs."
  },
  {
    "commentName": "PR50V",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 50.0,
      "aas": "V"
    },
    "comment": "I50V is a non-polymorphic mutation selected by DRV, LPV and FPV. It causes low-level, intermediate, and high-level resistance to DRV, LPV, and FPV, respectively. It is included in the Tibotec DRV genotypic susceptibility score."
  },
  {
    "commentName": "PR53L",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 53.0,
      "aas": "L"
    },
    "comment": "F53L is a non-polymorphic accessory PI-selected mutation that reduces susceptibility primarily to ATV, SQV, and NFV."
  },
  {
    "commentName": "PR53Y",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 53.0,
      "aas": "Y"
    },
    "comment": "F53L is a non-polymorphic accessory PI-selected mutation which reduces susceptibility primarily to ATV, SQV, and NFV. F53Y is a rare non-polymorphic PI-selected mutation that has not been well studied. $listMutsIn{53(NOT LY)} is a highly unusual mutation at this position."
  },
  {
    "commentName": "PR54ATS",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 54.0,
      "aas": "ATS"
    },
    "comment": "I54A/T/S are non-polymorphic PI-selected mutations that occur almost exclusively in viruses with multiple PI-resistance mutations. I54A/T/S are associated with reduced susceptibility to each of the PIs except DRV."
  },
  {
    "commentName": "PR54CDEFGHKNPQRWY_-",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 54.0,
      "aas": "CDEFGHKNPQRWY_-"
    },
    "comment": "I54V/A/T/S reduce susceptibility to each of the PIs except DRV. I54M reduces susceptibility to each of the PIs. I54L reduces susceptibility to each of the PIs except TPV. $listMutsIn{54(NOT ALMSTV)} is a highly unusual mutation at this position."
  },
  {
    "commentName": "PR54LM",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 54.0,
      "aas": "LM"
    },
    "comment": "I54M/L are non-polymorphic mutations selected primarily by DRV and FPV. I54M reduces susceptibility to each of the PIs. I54L reduces susceptibility to each of the PIs except TPV. I54M/L are each included in the Tibotec DRV genotypic susceptibility score."
  },
  {
    "commentName": "PR54V",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 54.0,
      "aas": "V"
    },
    "comment": "I54V is a non-polymorphic PI-selected mutation that contributes reduced susceptibility to each of the PIs except DRV."
  },
  {
    "commentName": "PR58E",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 58.0,
      "aas": "E"
    },
    "comment": "Q58E is a non-polymorphic accessory PI-selected mutation associated with reduced susceptibility to TPV and possibly other PIs."
  },
  {
    "commentName": "PR71IL",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 71.0,
      "aas": "IL"
    },
    "comment": "A71I/L are non-polymorphic, PI-selected accessory mutations that appear to increase the replication of viruses with other PI-resistance mutations."
  },
  {
    "commentName": "PR71TV",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 71.0,
      "aas": "TV"
    },
    "comment": "A71V/T are polymorphic, PI-selected accessory mutations that increase the replication of viruses with other PI-resistance mutations."
  },
  {
    "commentName": "PR73EFHIKLMNPQRWY_-",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 73.0,
      "aas": "EFHIKLMNPQRWY_-"
    },
    "comment": "G73S/T/C/A/D/V are non-polymorphic accessory PI-selected mutations. They are associated primarily with reduced susceptibility to ATV, SQV, IDV, and NFV. $listMutsIn{73(NOT ACDSTV)} is an unusual mutation at this position that has not been well studied."
  },
  {
    "commentName": "PR73STCADV",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 73.0,
      "aas": "STCADV"
    },
    "comment": "G73S/T/C/A are non-polymorphic accessory PI-selected mutations. They are associated primarily with reduced susceptibility to ATV, SQV, FPV, IDV, and NFV. G73V/D are rare non-polymorphic PI-selected mutations."
  },
  {
    "commentName": "PR74P",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 74.0,
      "aas": "P"
    },
    "comment": "T74P is a non-polymorphic PI-selected accessory mutation that occurs primarily in viruses from patients who have received multiple PIs. It is associated with reduced susceptibility to each of the PIs. It is included in the Boehringer-Ingelheim TPV and Tibotec DRV genotypic susceptibility scores."
  },
  {
    "commentName": "PR74S",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 74.0,
      "aas": "S"
    },
    "comment": "T74S is a PI-selected accessory mutation that is polymorphic in most non-B subtypes."
  },
  {
    "commentName": "PR76ACDEFGHIKMNPQRSTWY_-",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 76.0,
      "aas": "ACDEFGHIKMNPQRSTWY_-"
    },
    "comment": "L76V is a non-polymorphic mutation selected by IDV, LPV and DRV. It reduces susceptibility to these PIs and to FPV and NFV. It increases susceptibility to ATV, SQV and TPV. L76V is included in the Tibotec DRV genotypic susceptibility score. $listMutsIn{76(NOT V)} is a highly unusual mutation at this position."
  },
  {
    "commentName": "PR76V",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 76.0,
      "aas": "V"
    },
    "comment": "L76V is a non-polymorphic mutation selected by IDV, LPV and DRV. It reduces susceptibility to these PIs and to FPV and NFV. It increases susceptibility to ATV, SQV and TPV. L76V is included in the Tibotec DRV genotypic susceptibility score."
  },
  {
    "commentName": "PR82A",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 82.0,
      "aas": "A"
    },
    "comment": "V82A is a non-polymorphic mutation selected primarily by IDV and LPV. It reduces susceptibility to these PIs and contributes cross-resistance to each of the remaining PIs except DRV and TPV."
  },
  {
    "commentName": "PR82C",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 82.0,
      "aas": "C"
    },
    "comment": "V82C is an uncommon non-polymorphic mutation that occurs primarily in viruses with multiple other PI-resistance mutations. Its effects on PI susceptibility have not been well studied."
  },
  {
    "commentName": "PR82DEGHKNPQRWY_-",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 82.0,
      "aas": "DEGHKNPQRWY_-"
    },
    "comment": "V82A/T/S/F/C/M are non-polymorphic mutations selected primarily in patients who have received IDV, LPV, or multiple PIs. V82A/S/T are associated with reduced susceptibility to each of the PIs except DRV. V82F is associated with reduced susceptibility to each of the PIs. V82C/M usually occur in viruses with multiple additional PI-resistance mutations and have not been well studied. $listMutsIn{82(NOT ATIFLMSC)} is a highly unusual mutation at this position."
  },
  {
    "commentName": "PR82F",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 82.0,
      "aas": "F"
    },
    "comment": "V82F is a non-polymorphic mutation selected primarily by IDV and LPV. It reduces susceptibility to these PIs and contributes cross-resistance to each of the remaining PIs."
  },
  {
    "commentName": "PR82I",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 82.0,
      "aas": "I"
    },
    "comment": "V82I is a highly polymorphic mutation that is not selected by PIs. It is the consensus amino acid in subtype G viruses."
  },
  {
    "commentName": "PR82L",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 82.0,
      "aas": "L"
    },
    "comment": "V82L is an uncommon non-polymorphic mutation selected by TPV. It reduces TPV susceptibility but its effects on other PIs have not been well studied."
  },
  {
    "commentName": "PR82M",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 82.0,
      "aas": "M"
    },
    "comment": "In most subtypes, V82M is a 2-base-pair mutation that develops in viruses with multiple other PI-resistance mutations. In subtype G, V82M is a 1-base-pair mutation. V82M reduces susceptibility to IDV, LPV and possibly other PIs."
  },
  {
    "commentName": "PR82TS",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 82.0,
      "aas": "TS"
    },
    "comment": "V82T/S are non-polymorphic PI-selected mutations. They are associated with reduced susceptibility to each of the PIs except DRV. V82T is included in the Boehringer-Ingelheim TPV genotypic susceptibility score."
  },
  {
    "commentName": "PR83D",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 83.0,
      "aas": "D"
    },
    "comment": "N83D is a non-polymorphic mutation selected primarily in patients who have received multiple PIs. It is included in the Boehringer-Ingelheim genotypic susceptibility score for TPV."
  },
  {
    "commentName": "PR84AC",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 84.0,
      "aas": "AC"
    },
    "comment": "I84A is an extremely rare non-polymorphic PI-selected substrate-cleft mutation associated with high-level resistance to each of the PIs except possibly DRV. I84C is an extremely rare non-polymorphic PI-selected mutation associated with varying degrees of reduced susceptibility to each of the PIs."
  },
  {
    "commentName": "PR84DEFGHKLMNPQRSTWY_-",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 84.0,
      "aas": "DEFGHKLMNPQRSTWY_-"
    },
    "comment": "I84V/A/C are non-polymorphic PI-selected substrate-cleft mutations associated with varying degrees of reduced susceptibility to each of the PIs. $listMutsIn{84(NOT ACV)} is a highly unusual mutation at this position."
  },
  {
    "commentName": "PR84V",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 84.0,
      "aas": "V"
    },
    "comment": "I84V is a non-polymorphic mutation selected by each of the PIs. It causes high-level resistance to ATV, FPV, IDV, NFV and SQV, intermediate resistance to LPV and TPV, and low-level resistance to DRV."
  },
  {
    "commentName": "PR85V",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 85.0,
      "aas": "V"
    },
    "comment": "I85V is a non-polymorphic PI-selected mutation. It has minimal, if any, effects on PI susceptibility."
  },
  {
    "commentName": "PR88ACEFHIKLMPQRVWY_-",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 88.0,
      "aas": "ACEFHIKLMPQRVWY_-"
    },
    "comment": "N88S is a non-polymorphic mutation usually selected by NFV, ATV, or IDV which causes high-level resistance to NFV and ATV and low-level resistance to IDV and SQV. It increases susceptibility to FPV. N88D is a non-polymorphic mutation selected by NFV usually in combination with D30N. $listMutsIn{88(NOT DGST)} is a highly unusual mutation at this position."
  },
  {
    "commentName": "PR88D",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 88.0,
      "aas": "D"
    },
    "comment": "N88D is a non-polymorphic mutation selected by NFV usually in combination with D30N. It reduces NFV susceptibility and may cause low-level cross-resistance to ATV and SQV."
  },
  {
    "commentName": "PR88S",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 88.0,
      "aas": "S"
    },
    "comment": "N88S is a non-polymorphic mutation usually selected by NFV, ATV, or IDV. It causes high-level resistance to NFV and ATV and low-level resistance to IDV and SQV. It increases susceptibility to DRV and FPV."
  },
  {
    "commentName": "PR88TG",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 88.0,
      "aas": "TG"
    },
    "comment": "N88G/T are extremely rare non-polymorphic PI-selected mutations that reduce susceptibility to NFV and ATV."
  },
  {
    "commentName": "PR89VT",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 89.0,
      "aas": "VT"
    },
    "comment": "L89V is a non-polymorphic PI-selected accessory mutation that contributes reduced susceptibility to FPV, DRV, NFV, and IDV. L89V is included in the Tibotec DRV genotypic susceptibility score. L89T is a rare non-polymorphic PI-selected mutation that has not been well studied."
  },
  {
    "commentName": "PR90ACDEFGHIKNPQRSTVWY_-",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 90.0,
      "aas": "ACDEFGHIKNPQRSTVWY_-"
    },
    "comment": "L90M is a non-polymorphic PI-selected mutation which reduces susceptibility to each of the PIs except TPV and DRV. $listMutsIn{90(NOT M)} is a highly unusual mutation at this position."
  },
  {
    "commentName": "PR90M",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "PR",
      "pos": 90.0,
      "aas": "M"
    },
    "comment": "L90M is a non-polymorphic PI-selected mutation that reduces susceptibility to each of the PIs except TPV and DRV."
  },
  {
    "commentName": "RT100ACDEFGHKMNPQRSTWY_-",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 100.0,
      "aas": "ACDEFGHKMNPQRSTWY_-"
    },
    "comment": "L100I is a non-polymorphic mutation that usually occurs in combination with K103N. In this setting it causes high-level resistance to NVP, EFV and RPV and intermediate resistance to ETR. It has a weight of 2.5 in the Tibotec ETR genotypic susceptibility score. $listMutsIn{100(NOT IV)} is a highly unusual mutation at this position."
  },
  {
    "commentName": "RT100I",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 100.0,
      "aas": "I"
    },
    "comment": "L100I is a non-polymorphic mutation that usually occurs in combination with K103N. In this setting it causes high-level resistance to NVP, EFV, and RPV and intermediate resistance to ETR. It has a weight of 2.5 in the Tibotec ETR genotypic susceptibility score. Preliminary data suggests it is contributes low to intermediate reductions in DOR susceptibility when it occurs in combination with K103N."
  },
  {
    "commentName": "RT100V",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 100.0,
      "aas": "V"
    },
    "comment": "L100I is a non-polymorphic mutation that usually occurs with K103N. In this setting it causes high-level resistance to NVP, EFV, and RPV and intermediate resistance to ETR. L100V is a rare non-polymorphic mutation with low / intermediate resistance to EFV, NVP, and RPV."
  },
  {
    "commentName": "RT101CDFGILMSVWY_-",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 101.0,
      "aas": "CDFGILMSVWY_-"
    },
    "comment": "K101E/H/P are NNRTI-resistance mutations. $listMutsIn{101(NOT AEHNPQRT)} is a highly unusual mutation at this position."
  },
  {
    "commentName": "RT101E",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 101.0,
      "aas": "E"
    },
    "comment": "K101E is a non-polymorphic primarily accessory mutation that causes intermediate resistance to NVP and RPV, low-level resistance to EFV, and potentially low-level resistance to ETR. It has a weight of 1.0 in the Tibotec ETR genotypic susceptibility score. It is associated with low-level reductions in DOR susceptibility."
  },
  {
    "commentName": "RT101H",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 101.0,
      "aas": "H"
    },
    "comment": "K101H is a non-polymorphic accessory mutation selected by NVP, EFV and ETR. When present with other NNRTI-resistance mutations, K101H further reduces susceptibility to these NNRTIs. It has a weight of 1.0 in the Tibotec ETR genotypic susceptibility score. Its effect on DOR susceptibility is not known."
  },
  {
    "commentName": "RT101NAT",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 101.0,
      "aas": "NAT"
    },
    "comment": "K101N/A/T are uncommon non-polymorphic NNRTI-selected mutation of uncertain phenotypic and clinical significance."
  },
  {
    "commentName": "RT101P",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 101.0,
      "aas": "P"
    },
    "comment": "K101P is a non-polymorphic mutation that causes high-level resistance to each of the NNRTIs. It has a weight of 2.5 in the Tibotec ETR genotypic susceptibility score. Its does not appear to reduce DOR susceptibility."
  },
  {
    "commentName": "RT101Q",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 101.0,
      "aas": "Q"
    },
    "comment": "K101Q is a relatively non-polymorphic mutation that is weakly selected in patients receiving NVP and EFV. It is of uncertain phenotypic and clinical significance."
  },
  {
    "commentName": "RT103ACDFGILMPVWY_-",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 103.0,
      "aas": "ACDFGILMPVWY_-"
    },
    "comment": "K103N/S/T/H are NNRTI-resistance mutations. K103R/E/Q are variants that do not reduce NNRTI susceptibility. $listMutsIn{103(NOT EHNQRST)} is a highly unusual mutation at this position."
  },
  {
    "commentName": "RT103EQ",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 103.0,
      "aas": "EQ"
    },
    "comment": "K103E/Q are rare mutations that have not been associated with reduced NNRTI susceptibility."
  },
  {
    "commentName": "RT103H",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 103.0,
      "aas": "H"
    },
    "comment": "K103H is a rare non-polymorphic mutation that causes high-level resistance to NVP and EFV."
  },
  {
    "commentName": "RT103N",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 103.0,
      "aas": "N"
    },
    "comment": "K103N is a non-polymorphic mutation that causes high-level reductions in NVP and EFV susceptibility."
  },
  {
    "commentName": "RT103R",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 103.0,
      "aas": "R"
    },
    "comment": "K103R is a polymorphic mutation that alone has no effect on NNRTI susceptibility. However, in combination with V179D, it reduces NVP and EFV susceptibility about 15-fold."
  },
  {
    "commentName": "RT103S",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 103.0,
      "aas": "S"
    },
    "comment": "K103S is a non-polymorphic mutation that causes high-level reductions in NVP susceptibility but intermediate reductions in EFV susceptibility. Because K103S is a 2-bp change from the wildtype K and a 1-bp change from K103N, persons with K103S may be likely to have once had K103N."
  },
  {
    "commentName": "RT103T",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 103.0,
      "aas": "T"
    },
    "comment": "K103T is an extremely rare non-polymorphic mutation that appears to cause intermediate/high-level resistance to NVP. It has little if any effect on EFV susceptibility."
  },
  {
    "commentName": "RT106A",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 106.0,
      "aas": "A"
    },
    "comment": "V106A is a non-polymorphic mutation that causes high-level resistance to NVP and intermediate resistance to EFV. It is selected in vitro and in vivo by DOR and alone it causes intermediate reductions in DOR susceptibility. In combination with other DOR-associated DRMs it is associated with high-level DOR resistance."
  },
  {
    "commentName": "RT106CDEFGHKLNPQRSTWY_-",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 106.0,
      "aas": "CDEFGHKLNPQRSTWY_-"
    },
    "comment": "V106A/M are NNRTI-resistance mutations. $listMutsIn{106(NOT AIM)} is a highly unusual mutation at this position."
  },
  {
    "commentName": "RT106I",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 106.0,
      "aas": "I"
    },
    "comment": "V106I is occurs in 1% to 2% of viruses from untreated persons. It contributes to reduced NNRTI susceptibility in combination with other mutations. It has a weight of 1.5 in the Tibotec ETR genotypic susceptibility score despite not contributing much to reduced ETR susceptibility. It likely plays a greater role in reducing DOR susceptibility, particularly in combination with other NNRTI-associated DRMs. "
  },
  {
    "commentName": "RT106M",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 106.0,
      "aas": "M"
    },
    "comment": "V106M is a non-polymorphic mutation that causes high-level resistance to NVP and EFV. It is selected in vitro and in vivo by DOR and preliminary data suggests it is associated with low/intermediate reductions in DOR susceptibility."
  },
  {
    "commentName": "RT108ACDEFGHKLMNPQRSTWY_-",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 108.0,
      "aas": "ACDEFGHKLMNPQRSTWY_-"
    },
    "comment": "V108I is a relatively non-polymorphic accessory mutation selected in vitro and/or in vivo with each of the NNRTIs. $listMutsIn{108(NOT I)} is a highly unusual mutation at this position."
  },
  {
    "commentName": "RT108I",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 108.0,
      "aas": "I"
    },
    "comment": "V108I is a relatively non-polymorphic accessory mutation selected in vitro and/or in vivo with each of the NNRTIs. It causes low-level reductions in susceptibility to NVP and DOR. Alone, it does not appear to reduce susceptibility to EFV, ETR, or RPV."
  },
  {
    "commentName": "RT115ACDEGHIKLMNPQRSTVW_-",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 115.0,
      "aas": "ACDEGHIKLMNPQRSTVW_-"
    },
    "comment": "Y115F causes intermediate resistance to ABC and low-level resistance to TDF. $listMutsIn{115(NOT F)} is a highly unusual mutation at this position."
  },
  {
    "commentName": "RT115F",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 115.0,
      "aas": "F"
    },
    "comment": "Y115F causes intermediate resistance to ABC and low-level resistance to TDF."
  },
  {
    "commentName": "RT116ACDEGHIKLMNPQRSTVW_-",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 116.0,
      "aas": "ACDEGHIKLMNPQRSTVW_-"
    },
    "comment": "F116Y usually occurs in combination with the multi-NRTI resistance mutation Q151M. $listMutsIn{116(NOT Y)} is a highly unusual mutation at this position."
  },
  {
    "commentName": "RT116Y",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 116.0,
      "aas": "Y"
    },
    "comment": "F116Y usually occurs in combination with the multi-NRTI resistance mutation Q151M."
  },
  {
    "commentName": "RT118I",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 118.0,
      "aas": "I"
    },
    "comment": "V118I is a polymorphic accessory NRTI-resistance mutation that often occurs in combination with multiple TAMs."
  },
  {
    "commentName": "RT132ML",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 132.0,
      "aas": "ML"
    },
    "comment": "I132M is an extremely rare non-polymorphic mutation associated with uncertain amount of reduced NVP and EFV susceptibility. I132L is a more common, non-polymorphic NNRTI-selected mutation that has not been well studied."
  },
  {
    "commentName": "RT138A",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 138.0,
      "aas": "A"
    },
    "comment": "E138A is a common polymorphic accessory mutation weakly selected in patients receiving ETR and RPV. It reduces ETR and RPV susceptibility ~2-fold. It has a weight of 1.5 in the Tibotec ETR genotypic susceptibility score."
  },
  {
    "commentName": "RT138CDFHILMNPSTVWY_-",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 138.0,
      "aas": "CDFHILMNPSTVWY_-"
    },
    "comment": "E138K is a non-polymorphic RPV-resistance mutation. E138A/Q/G/R are less well studied mutations associated with reduced ETR and RPV susceptibility. $listMutsIn{138(NOT AGKQR)} is an unusual mutation at this position."
  },
  {
    "commentName": "RT138K",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 138.0,
      "aas": "K"
    },
    "comment": "E138K is a non-polymorphic mutation selected in a high proportion of patients receiving RPV. It reduces RPV susceptibility by 2 to 3-fold and in combination with K101E or the NRTI-resistance mutation M184I, it is sufficient to cause virological failure on a first-line RPV-containing regimen. E138K causes low-level cross-resistance to ETR but no cross-resistance to NVP, EFV, or DOR."
  },
  {
    "commentName": "RT138QG",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 138.0,
      "aas": "QG"
    },
    "comment": "E138Q/G are non-polymorphic accessory mutations frequently selected in patients receiving ETR and RPV and occasionally in patients receiving NVP and EFV. In most studies, they cause low-level reductions in susceptibility to NVP, RPV, and ETR."
  },
  {
    "commentName": "RT138R",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 138.0,
      "aas": "R"
    },
    "comment": "E138R is a rare non-polymorphic accessory mutation selected in vitro by RPV. It is associated with 2 to 3-fold reduced susceptibility to ETR and RPV."
  },
  {
    "commentName": "RT151ACDEFGHIKNPRSTVWY_-",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 151.0,
      "aas": "ACDEFGHIKNPRSTVWY_-"
    },
    "comment": "Q151M causes intermediate/high-level resistance to AZT, ddI, d4T and ABC and low-level resistance to TDF, 3TC and FTC. In combination with accessory mutations at positions 62, 75, 77, and 116, Q151M confers high-level resistance to AZT, ddI, d4T and ABC and intermediate resistance to TDF, 3TC and FTC. Q151L is an extremely rare transitional mutation that may precede the emergence of the Q151M. $listMutsIn{151(NOT ML)} is a highly unusual mutation at this position."
  },
  {
    "commentName": "RT151L",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 151.0,
      "aas": "L"
    },
    "comment": "Q151M causes intermediate/high-level resistance to AZT, ddI, d4T and ABC and low-level resistance to TDF, 3TC and FTC. In combination with accessory mutations at positions 62, 75, 77, and 116, Q151M confers high-level resistance to AZT, ddI, d4T and ABC and intermediate resistance to TDF, 3TC and FTC. Q151L is an extremely rare transitional mutation that may precede the emergence of the Q151M."
  },
  {
    "commentName": "RT151M",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 151.0,
      "aas": "M"
    },
    "comment": "Q151M causes intermediate/high-level resistance to AZT, ddI, d4T and ABC and low-level resistance to TDF, 3TC and FTC. In combination with accessory mutations at positions 62, 75, 77, and 116, Q151M confers high-level resistance to AZT, ddI, d4T and ABC and intermediate resistance to TDF, 3TC and FTC."
  },
  {
    "commentName": "RT179ACGHKMNPQRSWY_-",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 179.0,
      "aas": "ACGHKMNPQRSWY_-"
    },
    "comment": "V179D/E/F/T/L are accessory NNRTI-resistance mutations. $listMutsIn{179(NOT DEFILT)} is an unusual mutation at this position."
  },
  {
    "commentName": "RT179DE",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 179.0,
      "aas": "DE"
    },
    "comment": "V179D is a polymorphic accessory NNRTI-selected mutation. It contributes low-levels reductions in susceptibility to each of the NNRTIs. The combination of V179D and K103R act synergistically to reduce NVP and EFV susceptibility. V179D has a weight of 1.0 in the Tibotec ETR genotypic susceptibility score. V179E is a non-polymorphic mutation occasionally selected by NVP and EFV. V179E appears similar to V179D in its effects on NNRTIs. V179D/E do not appear to reduce the virological response to a first-line EFV-containing regimen."
  },
  {
    "commentName": "RT179F",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 179.0,
      "aas": "F"
    },
    "comment": "V179F is a non-polymorphic mutation frequently selected in patients receiving ETR. It nearly always occurs in combination with Y181C. Alone V179F has little effect on NNRTI susceptibility. In combination with Y181C, however, it is associated with high-level ETR and RPV resistance. It has a weight of 1.5 in the Tibotec ETR genotypic susceptibility score."
  },
  {
    "commentName": "RT179I",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 179.0,
      "aas": "I"
    },
    "comment": "V179I is a polymorphic mutation that is frequently selected in patients receiving ETR and RPV. But It has little, if any, direct effect on NNRTI susceptibility."
  },
  {
    "commentName": "RT179L",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 179.0,
      "aas": "L"
    },
    "comment": "V179L is a rare non-polymorphic mutation occasionally selected in patients receiving NNRTIs. Its effects on NNRTI susceptibility have not been well studied. It is listed as an RPV-associated resistance mutation in the RPV package-insert."
  },
  {
    "commentName": "RT179T",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 179.0,
      "aas": "T"
    },
    "comment": "V179T is a relatively rare non-polymorphic mutation occasionally selected in patients receiving NNRTIs. It is associated with minimal, if any, reduction in ETR and RPV susceptibility. It has a weight of 1.0 in the Tibotec ETR genotypic susceptibility score."
  },
  {
    "commentName": "RT181ADEHKLMNPQRTW_-",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 181.0,
      "aas": "ADEHKLMNPQRTW_-"
    },
    "comment": "Y181C/I/V are associated with intermediate or high-level resistance to NVP, ETR, and RPV. $listMutsIn{181(NOT CIVFSG)} is a highly unusual mutation at this position."
  },
  {
    "commentName": "RT181C",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 181.0,
      "aas": "C"
    },
    "comment": "Y181C is a non-polymorphic mutation selected in patients receiving NVP, ETR and RPV. It reduces susceptibility to NVP, ETR, RPV, and EFV by \u003e50-fold, 5-fold, 3-fold, and 2-fold, respectively. Although Y181C itself reduces EFV susceptibility by only 2-fold, it has been associated with a reduced response to an EFV-containing regimen in NNRTI-experienced patients. Y181C has a weight of 2.5 in the Tibotec ETR genotypic susceptibility score. Alone, it does not appear to reduce DOR susceptibility."
  },
  {
    "commentName": "RT181FSG",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 181.0,
      "aas": "FSG"
    },
    "comment": "Y181F/S/G are rare non-polymorphic NNRTI-associated mutations that are usually present as part of an electrophoretic mixture. They are likely to represent transitional mutations between Y and I or V."
  },
  {
    "commentName": "RT181IV",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 181.0,
      "aas": "IV"
    },
    "comment": "Y181I/V are 2-base pair non-polymorphic mutations selected by NVP and ETR. They cause high-level resistance to NVP, ETR, and RPV. They each have a weight of 3.0 in the Tibotec ETR genotypic susceptibility score. Their effects on DOR have not been well-characterized."
  },
  {
    "commentName": "RT184ACDEFGHKLNPQRSTWY_-",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 184.0,
      "aas": "ACDEFGHKLNPQRSTWY_-"
    },
    "comment": "M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF, and d4T and are associated with clinically significant reductions in HIV-1 replication. $listMutsIn{184(NOT VI)} is a highly unusual mutation at this position."
  },
  {
    "commentName": "RT184VI",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 184.0,
      "aas": "VI"
    },
    "comment": "M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication."
  },
  {
    "commentName": "RT188ADEGIKMNPQRSTVW_-",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 188.0,
      "aas": "ADEGIKMNPQRSTVW_-"
    },
    "comment": "Y188L/H/C are NNRTI-resistance mutations. $listMutsIn{188(NOT CFHL)} is a highly unusual mutation at this position."
  },
  {
    "commentName": "RT188C",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 188.0,
      "aas": "C"
    },
    "comment": "Y188C is a non-polymorphic mutation selected in patients receiving NVP and EFV. It confers high-level resistance to NVP and EFV."
  },
  {
    "commentName": "RT188F",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 188.0,
      "aas": "F"
    },
    "comment": "Y188F is a rare non-polymorphic NNRTI-associated mutation that is usually present as part of an electrophoretic mixture. It appears to represent a transitional mutation between Y and L."
  },
  {
    "commentName": "RT188H",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 188.0,
      "aas": "H"
    },
    "comment": "Y188H is a non-polymorphic mutation selected in patients receiving NVP and EFV. It causes about 5 to 10-fold reduced susceptibility to NVP and EFV."
  },
  {
    "commentName": "RT188L",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 188.0,
      "aas": "L"
    },
    "comment": "Y188L is a non-polymorphic mutation that causes high-level resistance to NVP, EFV, RPV, and DOR, and potentially low-level resistance to ETR."
  },
  {
    "commentName": "RT190A",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 190.0,
      "aas": "A"
    },
    "comment": "G190A is a non-polymorphic mutation that causes high-level resistance to NVP and intermediate resistance to EFV. It has a weight of 1.0 in the Tibotec ETR genotypic susceptibility score but does not appear to be selected by ETR or RPV or to reduce their in vitro susceptibility in the absence of other NNRTI-resistance mutations. It also does not appear to reduce DOR susceptibility."
  },
  {
    "commentName": "RT190CTV",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 190.0,
      "aas": "CTV"
    },
    "comment": "G190C/T/V are rare non-polymorphic mutations that cause high-level resistance to NVP and EFV. Their effects on ETR, RPV, and DOR susceptibility are not known."
  },
  {
    "commentName": "RT190DFHIKLMNPWY_-",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 190.0,
      "aas": "DFHIKLMNPWY_-"
    },
    "comment": "G190A/S/E/Q/C/T/V are each associated with reduced susceptibility to one or more NNRTIs. $listMutsIn{190(NOT ACEQRSTV)} is a highly unusual mutation at this position."
  },
  {
    "commentName": "RT190EQ",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 190.0,
      "aas": "EQ"
    },
    "comment": "G190E is a non-polymorphic mutation that causes high-level resistance to each of the NNRTIs including DOR. G190Q is a less common non-polymorphic NNRTI-selected mutation that is associated with high-level NVP and EFV resistance. Its effects on RPV, ETR, and DOR susceptibility is not known."
  },
  {
    "commentName": "RT190R",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 190.0,
      "aas": "R"
    },
    "comment": "G190R is strongly suspicious for being an artifact of APOBEC-mediated G-to-A hypermutation. It has not been associated with reduced NNRTI susceptibility."
  },
  {
    "commentName": "RT190S",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 190.0,
      "aas": "S"
    },
    "comment": "G190S is a non-polymorphic mutation that causes high-level resistance to NVP and EFV. It has a weight of 1.5 in the Tibotec ETR genotypic susceptibility score but does not appear to be selected by ETR or RPV or to reduce their in vitro susceptibility in the absence of other NNRTI-resistance mutations. Preliminary data suggests it is associated with low/intermediate reductions in DOR susceptibility."
  },
  {
    "commentName": "RT210W",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 210.0,
      "aas": "W"
    },
    "comment": "L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF."
  },
  {
    "commentName": "RT215F",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 215.0,
      "aas": "F"
    },
    "comment": "T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF."
  },
  {
    "commentName": "RT215GHKMPQRW_-",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 215.0,
      "aas": "GHKMPQRW_-"
    },
    "comment": "T215Y/F cause intermediate/high-level resistance to AZT and d4T and low-level resistance to ABC, ddI and TDF. T215S/C/D/E/I/V/N/A/L do not reduce NRTI susceptibility but arise from viruses that once contained T215Y/F. The presence of one of these revertant mutations may suggest that the patient may have once had a majority virus population with T215Y/F. $listMutsIn{215(NOT YFSCDEIVALN)} is a highly unusual mutation at this position."
  },
  {
    "commentName": "RT215SCDEIVALN",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 215.0,
      "aas": "SCDEIVALN"
    },
    "comment": "T215Y/F cause intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF. T215S/C/D/E/I/V/N/A/L do not reduce NRTI susceptibility but arise from viruses that once contained T215Y/F. The presence of one of these revertant mutations suggests that the patient may have once had a majority virus population with T215Y/F."
  },
  {
    "commentName": "RT215Y",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 215.0,
      "aas": "Y"
    },
    "comment": "T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF."
  },
  {
    "commentName": "RT219ACDFGHILMPSTVY_-",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 219.0,
      "aas": "ACDFGHILMPSTVY_-"
    },
    "comment": "K219Q/E/N/R/W are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T. $listMutsIn{219(NOT QENRW)} is an unusual mutation at this position."
  },
  {
    "commentName": "RT219NR",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 219.0,
      "aas": "NR"
    },
    "comment": "K219N/R are accessory TAMS that usually occur in combination with multiple other TAMs."
  },
  {
    "commentName": "RT219QE",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 219.0,
      "aas": "QE"
    },
    "comment": "K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T."
  },
  {
    "commentName": "RT219W",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 219.0,
      "aas": "W"
    },
    "comment": "K219W is an uncommon NRTI-selected mutation."
  },
  {
    "commentName": "RT221Y",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 221.0,
      "aas": "Y"
    },
    "comment": "H221Y is a non-polymorphic accessory mutation selected primarily by NVP and RPV. It frequently occurs in combination with Y181C."
  },
  {
    "commentName": "RT225ACDEFGIKLMNQRSTVWY_-",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 225.0,
      "aas": "ACDEFGIKLMNQRSTVWY_-"
    },
    "comment": "P225H is a non-polymorphic EFV-selected mutation that usually occurs in combination with K103N. The combination of P225H and K103N synergistically reduces NVP, EFV and DOR susceptibility. $listMutsIn{225(NOT H)} is a highly unusual mutation at this position."
  },
  {
    "commentName": "RT225H",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 225.0,
      "aas": "H"
    },
    "comment": "P225H is a non-polymorphic EFV-selected mutation that usually occurs in combination with K103N. The combination of P225H and K103N synergistically reduces NVP, EFV and DOR susceptibility."
  },
  {
    "commentName": "RT227ADEGHKMNPQRSTWY_-",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 227.0,
      "aas": "ADEGHKMNPQRSTWY_-"
    },
    "comment": "F227L usually occurs together with V106A. This combination is associated with high-level resistance to NVP and EFV. F227C is a rare non-polymorphic mutation that usually occurs in combination with other NNRTI-resistance mutations. In this context it causes high-level resistance to each of the NNRTIs. $listMutsIn{227(NOT CILV)} is a highly unusual mutation at this position."
  },
  {
    "commentName": "RT227C",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 227.0,
      "aas": "C"
    },
    "comment": "F227C is a nonpolymorphic mutation selected in persons receiving DOR and rarely in persons receiving ETR and RPV. It usually occurs in combination with other DRMs and in this setting has consistently been associated with the highest possible levels of DOR resistance. It is also usually associated with intermediate or higher reductions in susceptibility to NVP, EFV, ETR, and RPV. "
  },
  {
    "commentName": "RT227ILV",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 227.0,
      "aas": "ILV"
    },
    "comment": "F227L is a non-polymorphic mutation that usually occurs in combination with V106A. It is selected in vivo and in vitro with both NVP and DOR. In this context it is associated with high-level reductions in NVP and DOR susceptibility and intermediate reductions in EFV susceptibility. F227I/V are extremely rare mutations that have been selected in vitro by DOR."
  },
  {
    "commentName": "RT230ACDEFGHKNPQRSTVWY_-",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 230.0,
      "aas": "ACDEFGHKNPQRSTVWY_-"
    },
    "comment": "M230L causes intermediate to high-level resistance to each of the NNRTIs. M230I is an extremely rare mutation selected in vitro by RPV. $listMutsIn{230(NOT IL)} is a highly unusual mutation at this position."
  },
  {
    "commentName": "RT230I",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 230.0,
      "aas": "I"
    },
    "comment": "M230I is an extremely rare mutation selected by RPV. Its effects on NNRTI susceptibility have not been well studied. It also often occurs as a result of APOBEC-mediated G-to-A hypermutation resulting in viruses that are likely to be noninfectious."
  },
  {
    "commentName": "RT230L",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 230.0,
      "aas": "L"
    },
    "comment": "M230L is an uncommon non-polymorphic mutation selected in persons receiving EFV, NVP, and RPV. It causes intermediate to high-level resistance to each of the NNRTIs."
  },
  {
    "commentName": "RT234ACDEFGHKLMNPQRSTWY_-",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 234.0,
      "aas": "ACDEFGHKLMNPQRSTWY_-"
    },
    "comment": "L234I is a nonpolymorphic mutation selected in persons receiving NVP and EFV. It is also selected in vitro by ETR and DOR. In combination with V106A, it is associated with high-level DOR resistance. Its effect on susceptibility when it occurs alone has not been studied. $listMutsIn{108(NOT I)} is a highly unusual mutation at this position."
  },
  {
    "commentName": "RT234I",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 234.0,
      "aas": "I"
    },
    "comment": "L234I is a nonpolymorphic mutation selected in persons receiving NVP and EFV. It is also selected in vitro by ETR and DOR. In combination with V106A, it is associated with high-level DOR resistance. Its effect on susceptibility when it occurs alone has not been studied."
  },
  {
    "commentName": "RT236ACDEFGHIKMNQRSTVWY_-",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 236.0,
      "aas": "ACDEFGHIKMNQRSTVWY_-"
    },
    "comment": "P236L is a non-polymorphic mutation that causes high-level DLV resistance but does not reduce susceptibility to any other NNRTIs. $listMutsIn{236(NOT L)} is a highly unusual mutation at this position."
  },
  {
    "commentName": "RT236L",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 236.0,
      "aas": "L"
    },
    "comment": "P236L is a non-polymorphic mutation that causes high-level DLV resistance but does not reduce susceptibility to any other NNRTIs."
  },
  {
    "commentName": "RT238ACDEFGHILMPQSVWY_-",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 238.0,
      "aas": "ACDEFGHILMPQSVWY_-"
    },
    "comment": "K238T reduces NVP and EFV susceptibility by about 5-fold. It may also reduce susceptibility to ETR and RPV. $listMutsIn{238(NOT NRT)} is a highly unusual mutation at this position."
  },
  {
    "commentName": "RT238R",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 238.0,
      "aas": "R"
    },
    "comment": "K238R is a common polymorphism that does not reduce NNRTI susceptibility."
  },
  {
    "commentName": "RT238TN",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 238.0,
      "aas": "TN"
    },
    "comment": "K238T is a non-polymorphic mutation selected in patients receiving NVP and EFV. It usually occurs in combination with K103N. It reduces susceptibility to NVP and EFV by about 5-fold. It may also reduce susceptibility to ETR and RPV. K238N is a non-polymorphic accessory mutation that is also selected by NVP and EFV. It appears to have minimal, if any, effects on NNRTI susceptibility."
  },
  {
    "commentName": "RT318ACDEGHIKLMNPQRSTVW_-",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 318.0,
      "aas": "ACDEGHIKLMNPQRSTVW_-"
    },
    "comment": "Y318F is an uncommon mutation that causes intermediate NVP resistance and potentially low-level EFV resistance. $listMutsIn{318(NOT F)} is a highly unusual mutation at this position."
  },
  {
    "commentName": "RT318F",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 318.0,
      "aas": "F"
    },
    "comment": "Y318F is an uncommon mutation that causes intermediate NVP resistance and potentially low-level EFV resistance. It has been selected in vivo by DOR but its effect on DOR susceptibility has not been studied."
  },
  {
    "commentName": "RT348ACDEFGHKLMPQRSTVWY_-",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 348.0,
      "aas": "ACDEFGHKLMPQRSTVWY_-"
    },
    "comment": "N348I is a non-polymorphic accessory mutation selected by the NRTIs AZT and d4T and by NVP and EFV. Alone it reduces AZT and NVP susceptibility by about 3-fold and EFV susceptibility by 2-fold. $listMutsIn{348(NOT I)} is an unusual mutation at this position."
  },
  {
    "commentName": "RT348I",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 348.0,
      "aas": "I"
    },
    "comment": "N348I is a non-polymorphic accessory mutation selected by NVP and EFV and the NRTIs AZT and D4T. Alone it reduces AZT and NVP susceptibility by about 3-fold and EFV susceptibility by 2-fold."
  },
  {
    "commentName": "RT40F",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 40.0,
      "aas": "F"
    },
    "comment": "E40F is a non-polymorphic accessory mutation selected by AZT and d4T. It usually occurs in combination with M41L, L210W and T215Y. In this context it is associated with reduced susceptibility to each of the NRTIs."
  },
  {
    "commentName": "RT41I",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 41.0,
      "aas": "I"
    },
    "comment": "M41I is usually an artifact resulting from APOBEC3G-mediated hypermutation."
  },
  {
    "commentName": "RT41L",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 41.0,
      "aas": "L"
    },
    "comment": "M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility."
  },
  {
    "commentName": "RT44AD",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 44.0,
      "aas": "AD"
    },
    "comment": "E44D is a relatively non-polymorphic accessory mutation and E44A is a nonpolymorphic accessory mutation. Each usually occurs with multiple TAMs."
  },
  {
    "commentName": "RT62V",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 62.0,
      "aas": "V"
    },
    "comment": "A62V is an accessory mutation that often occurs in combination with the multi-NRTI resistance mutations K65R or Q151M. A62V is widespread in subtype A viruses in former Soviet Union countries but A62 is otherwise non-polymorphic."
  },
  {
    "commentName": "RT65ACDFGHILMPQSTVWY_-",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 65.0,
      "aas": "ACDFGHILMPQSTVWY_-"
    },
    "comment": "K65R causes intermediate/high-level resistance to TDF, ddI, ABC and d4T and low/intermediate resistance to 3TC and FTC. K65R increases susceptibility to AZT. $listMutsIn{65(NOT NRE)} is a highly unusual mutation at this position."
  },
  {
    "commentName": "RT65E",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 65.0,
      "aas": "E"
    },
    "comment": "K65R causes intermediate/high-level resistance to TDF, ddI, ABC and d4T and low/intermediate resistance to 3TC and FTC. K65R increases susceptibility to AZT. K65E is an extremely rare NRTI-selected mutation with markedly reduced replication fitness."
  },
  {
    "commentName": "RT65N",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 65.0,
      "aas": "N"
    },
    "comment": "K65R causes intermediate/high-level resistance to TDF, ddI, ABC and d4T and low/intermediate resistance to 3TC and FTC. K65R increases susceptibility to AZT. K65N is a rare mutation with similar but less pronounced effects on NRTI susceptibility than K65R."
  },
  {
    "commentName": "RT65R",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 65.0,
      "aas": "R"
    },
    "comment": "K65R causes intermediate/high-level resistance to TDF, ddI, ABC and d4T and low/intermediate resistance to 3TC and FTC. K65R increases susceptibility to AZT."
  },
  {
    "commentName": "RT67-",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 67.0,
      "aas": "-"
    },
    "comment": "Amino acid deletions between codons 67 and 70 are rare and usually occur in combination with multiple TAMs, K65R, or the Q151M mutation complex. Deletions at position 67 are more often associated with multiple TAMs. Deletions at positions 69 and 70 are more often associated with K65R or the Q151M mutation complex."
  },
  {
    "commentName": "RT67ACFIKLMPQRVWY_",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 67.0,
      "aas": "ACFIKLMPQRVWY_"
    },
    "comment": "D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs. $listMutsIn{67(NOT NGESTHd)} is a highly unusual mutation at this position."
  },
  {
    "commentName": "RT67GESTH",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 67.0,
      "aas": "GESTH"
    },
    "comment": "D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs."
  },
  {
    "commentName": "RT67N",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 67.0,
      "aas": "N"
    },
    "comment": "D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF."
  },
  {
    "commentName": "RT68-",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 68.0,
      "aas": "-"
    },
    "comment": "Amino acid deletions between codons 67 and 70 are rare and usually occur in combination with multiple TAMs, K65R, or the Q151M mutation complex. Deletions at position 67 are more often associated with multiple TAMs. Deletions at positions 69 and 70 are more often associated with K65R or the Q151M mutation complex. Deletions at codon 68 are extremely rare and less well characterized."
  },
  {
    "commentName": "RT68G",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 68.0,
      "aas": "G"
    },
    "comment": "S68G is a polymorphic mutation that is often selected in combination with K65R. It partially restores the replication defect associated with K65R."
  },
  {
    "commentName": "RT69-",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 69.0,
      "aas": "-"
    },
    "comment": "Amino acid deletions between codons 67 and 70 are rare and usually occur in combination with multiple TAMs, K65R, or the Q151M mutation complex. Deletions at position 67 are more often associated with multiple TAMs. Deletions at positions 69 and 70 are more often associated with K65R or the Q151M mutation complex."
  },
  {
    "commentName": "RT69CFHKLMPQRVWY",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 69.0,
      "aas": "CFHKLMPQRVWY"
    },
    "comment": "T69D/N/G/S/A/I/E are NRTI-selected mutations. $listMutsIn{69(NOT DNGSAIEid)} is a highly unusual mutation at this position."
  },
  {
    "commentName": "RT69D",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 69.0,
      "aas": "D"
    },
    "comment": "T69D is a non-polymorphic mutation that reduces susceptibility to ddI and possibly d4T."
  },
  {
    "commentName": "RT69G",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 69.0,
      "aas": "G"
    },
    "comment": "T69G is a rare non-polymorphic mutation that usually occurs in viruses with a deletion at codon 67 and multiple other NRTI-resistance mutations."
  },
  {
    "commentName": "RT69N",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 69.0,
      "aas": "N"
    },
    "comment": "T69N is a relatively non-polymorphic mutation weakly selected in patients receiving NRTIs. In combination with TAMs, it may contribute minimally reduced susceptibility to ddI, d4T, and AZT."
  },
  {
    "commentName": "RT69SAIE",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 69.0,
      "aas": "SAIE"
    },
    "comment": "T69S/A/I/E are relatively polymorphic mutations weakly selected in patients receiving NRTIs. Their effects on NRTI susceptibility have not been well studied."
  },
  {
    "commentName": "RT69_",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 69.0,
      "aas": "_"
    },
    "comment": "Amino acid insertions between codons 67 and 70 are by convention assigned to codon 69. Together with TAMs, they are associated with high-level resistance to AZT, d4T, ddI, ABC and TDF and intermediate to 3TC and FTC."
  },
  {
    "commentName": "RT70-",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 70.0,
      "aas": "-"
    },
    "comment": "Amino acid deletions between codons 67 and 70 are rare and usually occur in combination with multiple TAMs, K65R, or the Q151M mutation complex. Deletions at position 67 are more often associated with multiple TAMs. Deletions at positions 69 and 70 are more often associated with K65R or the Q151M mutation complex."
  },
  {
    "commentName": "RT70ACDFHILMPVWY_",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 70.0,
      "aas": "ACDFHILMPVWY_"
    },
    "comment": "K70R causes intermediate resistance to AZT and possibly low-level resistance to d4T and TDF. K70E/G cause low-level resistance to TDF, ABC, DDI and possibly 3TC and FTC. K70E increases susceptibility to AZT. $listMutsIn{70(NOT REGQNSTd)} is an unusual mutation at this position."
  },
  {
    "commentName": "RT70EG",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 70.0,
      "aas": "EG"
    },
    "comment": "K70E/G cause low-level resistance to TDF, ABC, DDI and possibly 3TC and FTC. K70E/G increase susceptibility to AZT."
  },
  {
    "commentName": "RT70QNST",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 70.0,
      "aas": "QNST"
    },
    "comment": "K70E/G cause low-level resistance to TDF, ABC, DDI and possibly 3TC and FTC. K70E/G increase susceptibility to AZT. K70Q/N/S/T are rare non-polymorphic NRTI-selected mutations that appear to have resistance profiles similar to K70E/G."
  },
  {
    "commentName": "RT70R",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 70.0,
      "aas": "R"
    },
    "comment": "K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF."
  },
  {
    "commentName": "RT74ACDEFGHKMNPQRSTWY_-",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 74.0,
      "aas": "ACDEFGHKMNPQRSTWY_-"
    },
    "comment": "L74V/I cause high-level resistance to ddI and intermediate resistance to ABC. $listMutsIn{74(NOT VI)} is a highly unusual mutation at this position."
  },
  {
    "commentName": "RT74VI",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 74.0,
      "aas": "VI"
    },
    "comment": "L74V/I cause high-level resistance to ddI and intermediate resistance to ABC."
  },
  {
    "commentName": "RT75CDEFGHKNPQRWY_-",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 75.0,
      "aas": "CDEFGHKNPQRWY_-"
    },
    "comment": "V75M/T/I/S/A are NRTI-selected mutations. $listMutsIn{75(NOT MTISAL)} is a highly unusual mutation at this position."
  },
  {
    "commentName": "RT75I",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 75.0,
      "aas": "I"
    },
    "comment": "V75I is a relatively non-polymorphic accessory mutation that often occurs in combination with the multi-NRTI resistance mutation Q151M. When V75I occurs alone its clinical significance is uncertain."
  },
  {
    "commentName": "RT75M",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 75.0,
      "aas": "M"
    },
    "comment": "V75M causes intermediate d4T resistance, low-level ddI resistance, and potentially low-level AZT resistance."
  },
  {
    "commentName": "RT75SA",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 75.0,
      "aas": "SA"
    },
    "comment": "V75S/A are non-polymorphic mutations that appear to reduce susceptibility to d4T and ddI."
  },
  {
    "commentName": "RT75T",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 75.0,
      "aas": "T"
    },
    "comment": "V75T causes high-level d4T resistance and intermediate ddI resistance."
  },
  {
    "commentName": "RT77ACDEGHIKMNPQRSTVWY_-",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 77.0,
      "aas": "ACDEGHIKMNPQRSTVWY_-"
    },
    "comment": "F77L usually occurs in combination with the multi-NRTI resistance mutation Q151M. When it occurs alone, its clinical significance is uncertain. $listMutsIn{77(NOT L)} is a highly unusual mutation at this position."
  },
  {
    "commentName": "RT77L",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 77.0,
      "aas": "L"
    },
    "comment": "F77L usually occurs in combination with the multi-NRTI resistance mutation Q151M. When it occurs alone, its clinical significance is uncertain."
  },
  {
    "commentName": "RT90I",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 90.0,
      "aas": "I"
    },
    "comment": "V90I is a polymorphic accessory mutation weakly selected by each of the NNRTIs. It has a weight of 1.0 in the Tibotec ETR genotypic susceptibility score but is associated with minimal, if any, detectable reduction in NNRTI susceptibility."
  },
  {
    "commentName": "RT98G",
    "drugClass": "NNRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "gene": "RT",
      "pos": 98.0,
      "aas": "G"
    },
    "comment": "A98G is a non-polymorphic accessory mutation associated with low-level reduced susceptibility to each of the NNRTIs."
  },
  {
    "commentName": "HIV2AIN118R",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "IN",
      "pos": 118.0,
      "aas": "R"
    },
    "comment": "G118R is an uncommon HIV-1-associated drug-resistance mutation which has not yet been reported in HIV-2 infected patients."
  },
  {
    "commentName": "HIV2AIN121Y",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "IN",
      "pos": 121.0,
      "aas": "Y"
    },
    "comment": "F121Y is an uncommon HIV-1-associated drug-resistance mutation which has not yet been reported in HIV-2 infected patients."
  },
  {
    "commentName": "HIV2AIN140SAC",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "IN",
      "pos": 140.0,
      "aas": "SAC"
    },
    "comment": "G140S is a nonpolymorphic HIV-1 associated drug-resistance mutation which is also selected by INSTIs in HIV-2-infected persons"
  },
  {
    "commentName": "HIV2AIN143CR",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "IN",
      "pos": 143.0,
      "aas": "CR"
    },
    "comment": "Y143C/R are non-polymorphic mutations associated with high-level RAL resistance. Alone, they have minimal effects on EVG susceptibility. However, they are associated with intermediate to high-level reductions in EVG susceptibility when they occur in combination with one or more accessory INSTI-resistance mutations. Y143 mutations do not reduce DTG or BIC susceptibility."
  },
  {
    "commentName": "HIV2AIN147G",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "IN",
      "pos": 147.0,
      "aas": "G"
    },
    "comment": "S147G is a non-polymorphic HIV-1-associated drug-resistance mutation that has also been reported in INSTI-experienced persons."
  },
  {
    "commentName": "HIV2AIN148HKR",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "IN",
      "pos": 148.0,
      "aas": "HKR"
    },
    "comment": "Q148H/K/R are nonpolymorphic HIV-1 associated drug-resistance mutation which are also selected by INSTIs in HIV-2-infected persons"
  },
  {
    "commentName": "HIV2AIN153G",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "IN",
      "pos": 153.0,
      "aas": "G"
    },
    "comment": "S153YF are extremely rare nonpolymorphic HIV-1-associated INSTI-resistance mutations. A153G is a nonpolymorphic HIV-2 mutation that is selected by INSTIs usually in combination with N155H"
  },
  {
    "commentName": "HIV2AIN155H",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "IN",
      "pos": 155.0,
      "aas": "H"
    },
    "comment": "N155H is a nonpolymorphic HIV-1 associated drug-resistance mutation which is also commonly selected by INSTIs in HIV-2-infected persons"
  },
  {
    "commentName": "HIV2AIN231_",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "IN",
      "pos": 231.0,
      "aas": "_"
    },
    "comment": "Among HIV-2 isolates, amino  acid insertions at position 231 are selected by INSTIs and associated with markedly reduced INSTI susceptibility."
  },
  {
    "commentName": "HIV2AIN263K",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "IN",
      "pos": 263.0,
      "aas": "K"
    },
    "comment": "R263K is a nonpolymorphic HIV-1-associated drug-resistance mutation which has also been reported in HIV-2 infected INSTI-experienced persons. "
  },
  {
    "commentName": "HIV2AIN51Y",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "IN",
      "pos": 51.0,
      "aas": "Y"
    },
    "comment": "H51Y is an uncommon HIV-1-associated drug-resistance mutation which has also been selected by INSTIs in HIV-2 infected patients."
  },
  {
    "commentName": "HIV2AIN66AIK",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "IN",
      "pos": 66.0,
      "aas": "AIK"
    },
    "comment": "T66AIK are HIV-1-associated drug-resistance mutation which have  not been reported in HIV-2 infected patients."
  },
  {
    "commentName": "HIV2AIN84V",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "IN",
      "pos": 84.0,
      "aas": "V"
    },
    "comment": "I84V is a polymorphic HIV-2 associated mutation that occurs significantly more commonly in INSTI-experienced compared with INSTI-nave persons."
  },
  {
    "commentName": "HIV2AIN92GAQ",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "IN",
      "pos": 92.0,
      "aas": "GAQ"
    },
    "comment": "E92Q is an HIV-1-associated drug resistance mutations which is also commonly selected by INSTIs in HIV-2 infected persons. E92G/A have also been reported in INSTI-experienced HIV-2-infected persons"
  },
  {
    "commentName": "HIV2AIN97A",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "IN",
      "pos": 97.0,
      "aas": "A"
    },
    "comment": "Among HIV-1 isolates, T97A is a minimally polymorphic accessory INSTI-selected mutation. Among HIV-2 isolates, T97A is a nonpolymorphic common INSTI-selected mutation."
  },
  {
    "commentName": "HIV2APR10I",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 10.0,
      "aas": "I"
    },
    "comment": "V10I is a minimally polymorphic mutation that occurs significantly more commonly in PI-treated than PI-nave HIV-2 isolates."
  },
  {
    "commentName": "HIV2APR23I",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 23.0,
      "aas": "I"
    },
    "comment": "L23I is an uncommon non-polymorphic HIV-1 associated PI-resistance mutation."
  },
  {
    "commentName": "HIV2APR30N",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 30.0,
      "aas": "N"
    },
    "comment": "D30N is a non-polymorphic mutation that causes high-level HIV-1 resistance to NFV."
  },
  {
    "commentName": "HIV2APR33I",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 33.0,
      "aas": "I"
    },
    "comment": "V33I is a minimally polymorphic mutation that occurs significantly more commonly in PI-treated than PI-nave HIV-2 isolates."
  },
  {
    "commentName": "HIV2APR45R",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 45.0,
      "aas": "R"
    },
    "comment": "K45R is a minimally polymorphic mutation that occurs significantly more commonly in PI-treated than PI-nave HIV-2 isolates."
  },
  {
    "commentName": "HIV2APR47A",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 47.0,
      "aas": "A"
    },
    "comment": "V47A is a non-polymorphic common PI-selected mutation that reduces HIV-2 susceptibility to LPV and other PIs.  "
  },
  {
    "commentName": "HIV2APR48VA",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 48.0,
      "aas": "VA"
    },
    "comment": "G48VA are non-polymorphic PI-selected HIV-2 mutations"
  },
  {
    "commentName": "HIV2APR50L",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 50.0,
      "aas": "L"
    },
    "comment": "I50L is a non-polymorphic HIV-2 mutation selected by ATV. It causes high-level resistance to ATV and increases susceptibility to most of the remaining PIs."
  },
  {
    "commentName": "HIV2APR50V",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 50.0,
      "aas": "V"
    },
    "comment": "I50V is a non-polymorphic PI-selected mutation that reduces HIV-2 susceptibility to LPV and other PIs.  "
  },
  {
    "commentName": "HIV2APR53Y",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 53.0,
      "aas": "Y"
    },
    "comment": "F53Y is a nonpolymorphic PI-selected HIV-2 mutation"
  },
  {
    "commentName": "HIV2APR54L",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 54.0,
      "aas": "L"
    },
    "comment": "I54L is a nonpolymorphic PI-selected mutation."
  },
  {
    "commentName": "HIV2APR54M",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 54.0,
      "aas": "M"
    },
    "comment": "I54M is a non-polymorphic common PI-selected mutation.  "
  },
  {
    "commentName": "HIV2APR56V",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 56.0,
      "aas": "V"
    },
    "comment": "T56V is a common nonpolymrophic mutation that occurs significantly more commonly in HIV-2 isolates from PI-treated vs. PI-nave isolates."
  },
  {
    "commentName": "HIV2APR71I",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 71.0,
      "aas": "I"
    },
    "comment": "V71I is a common polymorphic mutation that occurs significantly more commonly in PI-treated than PI-nave HIV-2 isolates."
  },
  {
    "commentName": "HIV2APR73G",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 73.0,
      "aas": "G"
    },
    "comment": "A73G is a nonpolymorphic mutation that occurs significantly more commonoly in PI-treated than PI-nave HIV-2 isolates."
  },
  {
    "commentName": "HIV2APR82F",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 82.0,
      "aas": "F"
    },
    "comment": "I82F is a non-polymorphic common PI-selected mutations that reduces HIV-2 susceptibility to LPV and other PIs."
  },
  {
    "commentName": "HIV2APR82LM",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 82.0,
      "aas": "LM"
    },
    "comment": "I82LM are nonpolymorphic PI-selected HIV-2 mutations."
  },
  {
    "commentName": "HIV2APR84V",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 84.0,
      "aas": "V"
    },
    "comment": "I84V is a non-polymorphic PI-selected HIV-2 mutation.  "
  },
  {
    "commentName": "HIV2APR85L",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 85.0,
      "aas": "L"
    },
    "comment": "I85V is a non-polymorphic PI-selected mutation. It has minimal, if any, effects on PI susceptibility."
  },
  {
    "commentName": "HIV2APR88D",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 88.0,
      "aas": "D"
    },
    "comment": "N88D is a nonpolymorphic HIV-1-associated PI resistance mutation that has been reported in one PI-treated HIV-2 isolate."
  },
  {
    "commentName": "HIV2APR90M",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 90.0,
      "aas": "M"
    },
    "comment": "L90M is a non-polymorphic PI-selected HIV-2 mutation. "
  },
  {
    "commentName": "HIV2APR95V",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 95.0,
      "aas": "V"
    },
    "comment": "M95V is a nonpolymorphic mutations that occurs significantly more common in PI-treated than PI-nave HIV-2 isolates."
  },
  {
    "commentName": "HIV2APR99F",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 99.0,
      "aas": "F"
    },
    "comment": "L99F is a nonpolymorphic mutations that occurs significantly more common in PI-treated than PI-nave HIV-2 isolates."
  },
  {
    "commentName": "HIV2ART111I",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 111.0,
      "aas": "I"
    },
    "comment": "V111I is a common polymorphic mutation that occurs significantly more commonly in HIV-2 sequences from NRTI-treated than NRTI-nave persons."
  },
  {
    "commentName": "HIV2ART115F",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 115.0,
      "aas": "F"
    },
    "comment": "Y11F is associated with reduced susceptibility to each of the NRTIs"
  },
  {
    "commentName": "HIV2ART116Y",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 116.0,
      "aas": "Y"
    },
    "comment": "F116Y is an accessory HIV-1-associated mutation that usually occurs in combination with the multi-NRTI resistance mutation Q151M. It has not been associated with NRTI therapy in HIV-2 isolates."
  },
  {
    "commentName": "HIV2ART151M",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 151.0,
      "aas": "M"
    },
    "comment": "Q151M causes high-level resistance to each of the NRTIs."
  },
  {
    "commentName": "HIV2ART184VI",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 184.0,
      "aas": "VI"
    },
    "comment": "M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication."
  },
  {
    "commentName": "HIV2ART195N",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 195.0,
      "aas": "N"
    },
    "comment": "D195N is a slighly polymorphic HIV-2 mutation that occurs with increased frequency in NRTI-treated persons."
  },
  {
    "commentName": "HIV2ART210ACDEFGHIKLMPQRSTVWY_",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 210.0,
      "aas": "ACDEFGHIKLMPQRSTVWY_"
    },
    "comment": "210W is an HIV-1 associated TAM. The HIV-2 consensus at this position is N. Mutations at this position have not been selected by NRTIs in HIV-2 isolates."
  },
  {
    "commentName": "HIV2ART214L",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 214.0,
      "aas": "L"
    },
    "comment": "F214L is a slighly polymorphic HIV-2 mutation that occurs with increased frequency in NRTI-treated persons."
  },
  {
    "commentName": "HIV2ART215YF",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 215.0,
      "aas": "YF"
    },
    "comment": "S215Y/F occur significantly more commonly in HIV-2 sequences from NRTI-treated than NRTI-nave persons but their effects on HIV-2 susceptibility to NRTIs is uncertain."
  },
  {
    "commentName": "HIV2ART219ACDFGHIKLMNPQRSTVWY_",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 219.0,
      "aas": "ACDFGHIKLMNPQRSTVWY_"
    },
    "comment": "219QENR are HIV-1 associated TAMs. The HIV-2 consensus  at this position is E. Mutations at this position have not been selected by NRTIs in HIV-2 isolates. "
  },
  {
    "commentName": "HIV2ART40R",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 40.0,
      "aas": "R"
    },
    "comment": "K40R occurs significantly more commonly in HIV-2 sequences from NRTI-treated than NRTI-nave persons."
  },
  {
    "commentName": "HIV2ART41L",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 41.0,
      "aas": "L"
    },
    "comment": "M41L is an HIV-1 associated TAM that has not been selected by NRTIs in HIV-2-infected persons and has not been associated with reduced HIV-2 susceptibility to NRTIs."
  },
  {
    "commentName": "HIV2ART62V",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 62.0,
      "aas": "V"
    },
    "comment": "A62V occurs significantly more commonly in HIV-2 sequences from NRTI-treated than NRTI-nave persons."
  },
  {
    "commentName": "HIV2ART65EN",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 65.0,
      "aas": "EN"
    },
    "comment": "K65R occurs significantly more commonly in HIV-2 sequences from NRTI-treated than NRTI-nave persons and is associated with reduced susceptibility to XXX.K65N/E are mutations that have rarely been selected by TDF, ABC, and d4T in HIV-1 isolates."
  },
  {
    "commentName": "HIV2ART65R",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 65.0,
      "aas": "R"
    },
    "comment": "K65R occurs significantly more commonly in HIV-2 sequences from NRTI-treated than NRTI-nave persons and is associated with reduced susceptibility to XXX."
  },
  {
    "commentName": "HIV2ART67NGESTH",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 67.0,
      "aas": "NGESTH"
    },
    "comment": "D67 mutations are commonly occurring HIV-1-assocated TAMs that are not selected in HIV-2 isolates."
  },
  {
    "commentName": "HIV2ART69-",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 69.0,
      "aas": "-"
    },
    "comment": "Deletions in the Beta3-Beta4 loop are associated with reduced HIV-1 susceptibility to each of the NRTIs but they have not been reported in HIV-2 isolates."
  },
  {
    "commentName": "HIV2ART69S",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 69.0,
      "aas": "S"
    },
    "comment": "N69S is a slighly polymorphic HIV-2 mutation that occurs with increased frequency in NRTI-treated persons."
  },
  {
    "commentName": "HIV2ART69_",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 69.0,
      "aas": "_"
    },
    "comment": "Insertions in the Beta3-Beta4 loop are associated with reduced HIV-1 susceptibility to each of the NRTIs but they have not been reported in HIV-2 isolates."
  },
  {
    "commentName": "HIV2ART70N",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 70.0,
      "aas": "N"
    },
    "comment": "K70N occurs significantly more commonly in HIV-2 sequences from NRTI-treated than NRTI-nave persons but its effects on HIV-2 susceptibility to NRTIs is uncertain."
  },
  {
    "commentName": "HIV2ART70R",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 70.0,
      "aas": "R"
    },
    "comment": "K70R occurs significantly more commonly in HIV-2 sequences from NRTI-treated than NRTI-nave persons but its effects on HIV-2 susceptibility to NRTIs is uncertain."
  },
  {
    "commentName": "HIV2ART74VI",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 74.0,
      "aas": "VI"
    },
    "comment": "L74VI are common HIV-1-associated NRTI-resistance mutations that have not been reported in HIV-2 sequences."
  },
  {
    "commentName": "HIV2ART75V",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 75.0,
      "aas": "V"
    },
    "comment": "I75V occurs significantly more commonly in HIV-2 sequences from NRTI-treated than NRTI-nave persons but its effects on HIV-2 susceptibility to NRTIs is uncertain."
  },
  {
    "commentName": "HIV2ART77L",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 77.0,
      "aas": "L"
    },
    "comment": "F77L is an accessory HIV-1-associated mutation that usually occurs in combination with the multi-NRTI resistance mutation Q151M. It has not been associated with NRTI therapy in HIV-2 isolates."
  },
  {
    "commentName": "HIV2BIN118R",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "IN",
      "pos": 118.0,
      "aas": "R"
    },
    "comment": "G118R is an uncommon HIV-1-associated drug-resistance mutation which has not yet been reported in HIV-2 infected patients."
  },
  {
    "commentName": "HIV2BIN121Y",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "IN",
      "pos": 121.0,
      "aas": "Y"
    },
    "comment": "F121Y is an uncommon HIV-1-associated drug-resistance mutation which has not yet been reported in HIV-2 infected patients."
  },
  {
    "commentName": "HIV2BIN140SAC",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "IN",
      "pos": 140.0,
      "aas": "SAC"
    },
    "comment": "G140S is a nonpolymorphic HIV-1 associated drug-resistance mutation which is also selected by INSTIs in HIV-2-infected persons"
  },
  {
    "commentName": "HIV2BIN143CR",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "IN",
      "pos": 143.0,
      "aas": "CR"
    },
    "comment": "Y143C/R are non-polymorphic mutations associated with high-level RAL resistance. Alone, they have minimal effects on EVG susceptibility. However, they are associated with intermediate to high-level reductions in EVG susceptibility when they occur in combination with one or more accessory INSTI-resistance mutations. Y143 mutations do not reduce DTG or BIC susceptibility."
  },
  {
    "commentName": "HIV2BIN147G",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "IN",
      "pos": 147.0,
      "aas": "G"
    },
    "comment": "S147G is a non-polymorphic HIV-1-associated drug-resistance mutation that has also been reported in INSTI-experienced persons."
  },
  {
    "commentName": "HIV2BIN148HKR",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "IN",
      "pos": 148.0,
      "aas": "HKR"
    },
    "comment": "Q148H/K/R are nonpolymorphic HIV-1 associated drug-resistance mutation which are also selected by INSTIs in HIV-2-infected persons"
  },
  {
    "commentName": "HIV2BIN153G",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "IN",
      "pos": 153.0,
      "aas": "G"
    },
    "comment": "S153YF are extremely rare nonpolymorphic HIV-1-associated INSTI-resistance mutations. A153G is a nonpolymorphic HIV-2 mutation that is selected by INSTIs usually in combination with N155H"
  },
  {
    "commentName": "HIV2BIN155H",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "IN",
      "pos": 155.0,
      "aas": "H"
    },
    "comment": "N155H is a nonpolymorphic HIV-1 associated drug-resistance mutation which is also commonly selected by INSTIs in HIV-2-infected persons"
  },
  {
    "commentName": "HIV2BIN231_",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "IN",
      "pos": 231.0,
      "aas": "_"
    },
    "comment": "Among HIV-2 isolates, amino  acid insertions at position 231 are selected by INSTIs and associated with markedly reduced INSTI susceptibility."
  },
  {
    "commentName": "HIV2BIN263K",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "IN",
      "pos": 263.0,
      "aas": "K"
    },
    "comment": "R263K is a nonpolymorphic HIV-1-associated drug-resistance mutation which has also been reported in HIV-2 infected INSTI-experienced persons. "
  },
  {
    "commentName": "HIV2BIN51Y",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "IN",
      "pos": 51.0,
      "aas": "Y"
    },
    "comment": "H51Y is an uncommon HIV-1-associated drug-resistance mutation which has also been selected by INSTIs in HIV-2 infected patients."
  },
  {
    "commentName": "HIV2BIN66AIK",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "IN",
      "pos": 66.0,
      "aas": "AIK"
    },
    "comment": "T66AIK are HIV-1-associated drug-resistance mutation which have  not been reported in HIV-2 infected patients."
  },
  {
    "commentName": "HIV2BIN84V",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "IN",
      "pos": 84.0,
      "aas": "V"
    },
    "comment": "I84V is a polymorphic HIV-2 associated mutation that occurs significantly more commonly in INSTI-experienced compared with INSTI-nave persons."
  },
  {
    "commentName": "HIV2BIN92GAQ",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "IN",
      "pos": 92.0,
      "aas": "GAQ"
    },
    "comment": "E92Q is an HIV-1-associated drug resistance mutations which is also commonly selected by INSTIs in HIV-2 infected persons. E92G/A have also been reported in INSTI-experienced HIV-2-infected persons"
  },
  {
    "commentName": "HIV2BIN97A",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "IN",
      "pos": 97.0,
      "aas": "A"
    },
    "comment": "Among HIV-1 isolates, T97A is a minimally polymorphic accessory INSTI-selected mutation. Among HIV-2 isolates, T97A is a nonpolymorphic common INSTI-selected mutation."
  },
  {
    "commentName": "HIV2BPR10I",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "PR",
      "pos": 10.0,
      "aas": "I"
    },
    "comment": "V10I is a minimally polymorphic mutation that occurs significantly more commonly in PI-treated than PI-nave HIV-2 isolates."
  },
  {
    "commentName": "HIV2BPR23I",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "PR",
      "pos": 23.0,
      "aas": "I"
    },
    "comment": "L23I is an uncommon non-polymorphic HIV-1 associated PI-resistance mutation."
  },
  {
    "commentName": "HIV2BPR30N",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "PR",
      "pos": 30.0,
      "aas": "N"
    },
    "comment": "D30N is a non-polymorphic mutation that causes high-level HIV-1 resistance to NFV."
  },
  {
    "commentName": "HIV2BPR33I",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "PR",
      "pos": 33.0,
      "aas": "I"
    },
    "comment": "V33I is a minimally polymorphic mutation that occurs significantly more commonly in PI-treated than PI-nave HIV-2 isolates."
  },
  {
    "commentName": "HIV2BPR45R",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "PR",
      "pos": 45.0,
      "aas": "R"
    },
    "comment": "K45R is a minimally polymorphic mutation that occurs significantly more commonly in PI-treated than PI-nave HIV-2 isolates."
  },
  {
    "commentName": "HIV2BPR47A",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "PR",
      "pos": 47.0,
      "aas": "A"
    },
    "comment": "V47A is a non-polymorphic common PI-selected mutation that reduces HIV-2 susceptibility to LPV and other PIs.  "
  },
  {
    "commentName": "HIV2BPR48VA",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "PR",
      "pos": 48.0,
      "aas": "VA"
    },
    "comment": "G48VA are non-polymorphic PI-selected HIV-2 mutations"
  },
  {
    "commentName": "HIV2BPR50L",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "PR",
      "pos": 50.0,
      "aas": "L"
    },
    "comment": "I50L is a non-polymorphic HIV-2 mutation selected by ATV. It causes high-level resistance to ATV and increases susceptibility to most of the remaining PIs."
  },
  {
    "commentName": "HIV2BPR50V",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "PR",
      "pos": 50.0,
      "aas": "V"
    },
    "comment": "I50V is a non-polymorphic PI-selected mutation that reduces HIV-2 susceptibility to LPV and other PIs.  "
  },
  {
    "commentName": "HIV2BPR53Y",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "PR",
      "pos": 53.0,
      "aas": "Y"
    },
    "comment": "F53Y is a nonpolymorphic PI-selected HIV-2 mutation"
  },
  {
    "commentName": "HIV2BPR54L",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "PR",
      "pos": 54.0,
      "aas": "L"
    },
    "comment": "I54L is a nonpolymorphic PI-selected mutation."
  },
  {
    "commentName": "HIV2BPR54M",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "PR",
      "pos": 54.0,
      "aas": "M"
    },
    "comment": "I54M is a non-polymorphic common PI-selected mutation.  "
  },
  {
    "commentName": "HIV2BPR56V",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "PR",
      "pos": 56.0,
      "aas": "V"
    },
    "comment": "T56V is a common nonpolymrophic mutation that occurs significantly more commonly in HIV-2 isolates from PI-treated vs. PI-nave isolates."
  },
  {
    "commentName": "HIV2BPR71I",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "PR",
      "pos": 71.0,
      "aas": "I"
    },
    "comment": "V71I is a common polymorphic mutation that occurs significantly more commonly in PI-treated than PI-nave HIV-2 isolates."
  },
  {
    "commentName": "HIV2BPR73G",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "PR",
      "pos": 73.0,
      "aas": "G"
    },
    "comment": "A73G is a nonpolymorphic mutation that occurs significantly more commonoly in PI-treated than PI-nave HIV-2 isolates."
  },
  {
    "commentName": "HIV2BPR82F",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "PR",
      "pos": 82.0,
      "aas": "F"
    },
    "comment": "I82F is a non-polymorphic common PI-selected mutations that reduces HIV-2 susceptibility to LPV and other PIs."
  },
  {
    "commentName": "HIV2BPR82LM",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "PR",
      "pos": 82.0,
      "aas": "LM"
    },
    "comment": "I82LM are nonpolymorphic PI-selected HIV-2 mutations."
  },
  {
    "commentName": "HIV2BPR84V",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "PR",
      "pos": 84.0,
      "aas": "V"
    },
    "comment": "I84V is a non-polymorphic PI-selected HIV-2 mutation.  "
  },
  {
    "commentName": "HIV2BPR85L",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "PR",
      "pos": 85.0,
      "aas": "L"
    },
    "comment": "I85V is a non-polymorphic PI-selected mutation. It has minimal, if any, effects on PI susceptibility."
  },
  {
    "commentName": "HIV2BPR88D",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "PR",
      "pos": 88.0,
      "aas": "D"
    },
    "comment": "N88D is a nonpolymorphic HIV-1-associated PI resistance mutation that has been reported in one PI-treated HIV-2 isolate."
  },
  {
    "commentName": "HIV2BPR90M",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "PR",
      "pos": 90.0,
      "aas": "M"
    },
    "comment": "L90M is a non-polymorphic PI-selected HIV-2 mutation. "
  },
  {
    "commentName": "HIV2BPR95V",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "PR",
      "pos": 95.0,
      "aas": "V"
    },
    "comment": "M95V is a nonpolymorphic mutations that occurs significantly more common in PI-treated than PI-nave HIV-2 isolates."
  },
  {
    "commentName": "HIV2BPR99F",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "PR",
      "pos": 99.0,
      "aas": "F"
    },
    "comment": "L99F is a nonpolymorphic mutations that occurs significantly more common in PI-treated than PI-nave HIV-2 isolates."
  },
  {
    "commentName": "HIV2BRT111I",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "RT",
      "pos": 111.0,
      "aas": "I"
    },
    "comment": "V111I is a common polymorphic mutation that occurs significantly more commonly in HIV-2 sequences from NRTI-treated than NRTI-nave persons."
  },
  {
    "commentName": "HIV2BRT115F",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "RT",
      "pos": 115.0,
      "aas": "F"
    },
    "comment": "Y11F is associated with reduced susceptibility to each of the NRTIs"
  },
  {
    "commentName": "HIV2BRT116Y",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "RT",
      "pos": 116.0,
      "aas": "Y"
    },
    "comment": "F116Y is an accessory HIV-1-associated mutation that usually occurs in combination with the multi-NRTI resistance mutation Q151M. It has not been associated with NRTI therapy in HIV-2 isolates."
  },
  {
    "commentName": "HIV2BRT151M",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "RT",
      "pos": 151.0,
      "aas": "M"
    },
    "comment": "Q151M causes high-level resistance to each of the NRTIs."
  },
  {
    "commentName": "HIV2BRT184VI",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "RT",
      "pos": 184.0,
      "aas": "VI"
    },
    "comment": "M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication."
  },
  {
    "commentName": "HIV2BRT195N",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "RT",
      "pos": 195.0,
      "aas": "N"
    },
    "comment": "D195N is a slighly polymorphic HIV-2 mutation that occurs with increased frequency in NRTI-treated persons."
  },
  {
    "commentName": "HIV2BRT210ACDEFGHIKLMPQRSTVWY_",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "RT",
      "pos": 210.0,
      "aas": "ACDEFGHIKLMPQRSTVWY_"
    },
    "comment": "210W is an HIV-1 associated TAM. The HIV-2 consensus at this position is N. Mutations at this position have not been selected by NRTIs in HIV-2 isolates."
  },
  {
    "commentName": "HIV2BRT214L",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "RT",
      "pos": 214.0,
      "aas": "L"
    },
    "comment": "F214L is a slighly polymorphic HIV-2 mutation that occurs with increased frequency in NRTI-treated persons."
  },
  {
    "commentName": "HIV2BRT215YF",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "RT",
      "pos": 215.0,
      "aas": "YF"
    },
    "comment": "S215Y/F occur significantly more commonly in HIV-2 sequences from NRTI-treated than NRTI-nave persons but their effects on HIV-2 susceptibility to NRTIs is uncertain."
  },
  {
    "commentName": "HIV2BRT219ACDFGHIKLMNPQRSTVWY_",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "RT",
      "pos": 219.0,
      "aas": "ACDFGHIKLMNPQRSTVWY_"
    },
    "comment": "219QENR are HIV-1 associated TAMs. The HIV-2 consensus  at this position is E. Mutations at this position have not been selected by NRTIs in HIV-2 isolates. "
  },
  {
    "commentName": "HIV2BRT40R",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "RT",
      "pos": 40.0,
      "aas": "R"
    },
    "comment": "K40R occurs significantly more commonly in HIV-2 sequences from NRTI-treated than NRTI-nave persons."
  },
  {
    "commentName": "HIV2BRT41L",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "RT",
      "pos": 41.0,
      "aas": "L"
    },
    "comment": "M41L is an HIV-1 associated TAM that has not been selected by NRTIs in HIV-2-infected persons and has not been associated with reduced HIV-2 susceptibility to NRTIs."
  },
  {
    "commentName": "HIV2BRT62V",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "RT",
      "pos": 62.0,
      "aas": "V"
    },
    "comment": "A62V occurs significantly more commonly in HIV-2 sequences from NRTI-treated than NRTI-nave persons."
  },
  {
    "commentName": "HIV2BRT65EN",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "RT",
      "pos": 65.0,
      "aas": "EN"
    },
    "comment": "K65R occurs significantly more commonly in HIV-2 sequences from NRTI-treated than NRTI-nave persons and is associated with reduced susceptibility to XXX.K65N/E are mutations that have rarely been selected by TDF, ABC, and d4T in HIV-1 isolates."
  },
  {
    "commentName": "HIV2BRT65R",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "RT",
      "pos": 65.0,
      "aas": "R"
    },
    "comment": "K65R occurs significantly more commonly in HIV-2 sequences from NRTI-treated than NRTI-nave persons and is associated with reduced susceptibility to XXX."
  },
  {
    "commentName": "HIV2BRT67NGESTH",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "RT",
      "pos": 67.0,
      "aas": "NGESTH"
    },
    "comment": "D67 mutations are commonly occurring HIV-1-assocated TAMs that are not selected in HIV-2 isolates."
  },
  {
    "commentName": "HIV2BRT69-",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "RT",
      "pos": 69.0,
      "aas": "-"
    },
    "comment": "Deletions in the Beta3-Beta4 loop are associated with reduced HIV-1 susceptibility to each of the NRTIs but they have not been reported in HIV-2 isolates."
  },
  {
    "commentName": "HIV2BRT69S",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "RT",
      "pos": 69.0,
      "aas": "S"
    },
    "comment": "N69S is a slighly polymorphic HIV-2 mutation that occurs with increased frequency in NRTI-treated persons."
  },
  {
    "commentName": "HIV2BRT69_",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "RT",
      "pos": 69.0,
      "aas": "_"
    },
    "comment": "Insertions in the Beta3-Beta4 loop are associated with reduced HIV-1 susceptibility to each of the NRTIs but they have not been reported in HIV-2 isolates."
  },
  {
    "commentName": "HIV2BRT70N",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "RT",
      "pos": 70.0,
      "aas": "N"
    },
    "comment": "K70N occurs significantly more commonly in HIV-2 sequences from NRTI-treated than NRTI-nave persons but its effects on HIV-2 susceptibility to NRTIs is uncertain."
  },
  {
    "commentName": "HIV2BRT70R",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "RT",
      "pos": 70.0,
      "aas": "R"
    },
    "comment": "K70R occurs significantly more commonly in HIV-2 sequences from NRTI-treated than NRTI-nave persons but its effects on HIV-2 susceptibility to NRTIs is uncertain."
  },
  {
    "commentName": "HIV2BRT74VI",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "RT",
      "pos": 74.0,
      "aas": "VI"
    },
    "comment": "L74VI are common HIV-1-associated NRTI-resistance mutations that have not been reported in HIV-2 sequences."
  },
  {
    "commentName": "HIV2BRT75V",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "RT",
      "pos": 75.0,
      "aas": "V"
    },
    "comment": "I75V occurs significantly more commonly in HIV-2 sequences from NRTI-treated than NRTI-nave persons but its effects on HIV-2 susceptibility to NRTIs is uncertain."
  },
  {
    "commentName": "HIV2BRT77L",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "RT",
      "pos": 77.0,
      "aas": "L"
    },
    "comment": "F77L is an accessory HIV-1-associated mutation that usually occurs in combination with the multi-NRTI resistance mutation Q151M. It has not been associated with NRTI therapy in HIV-2 isolates."
  }
]